| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | ERVK-6 ERBB2 ATR TRIO PDGFRA SRC OBSCN ERVK-7 GCK IDNK TYK2 PIK3R4 PIP5KL1 FES PPP1R9B UAP1L1 CDC42BPG CDC42BPA RET TEK YES1 MAP3K6 CDC42BPB POLR3A TRNT1 TKFC TIE1 EGFR MTOR FLAD1 ERVK-8 ROCK1 MAPK1 MAPK4 PALS2 EPHA3 | 3.44e-07 | 938 | 304 | 36 | GO:0016772 |
| GeneOntologyMolecularFunction | actin filament binding | MYO6 SPTAN1 SPTB SPTBN2 ACTN3 SPTBN5 PPP1R9B FMNL1 ESPN MYH7B SPTBN4 GAS2L1 EGFR MYH14 MYH15 | 2.24e-06 | 227 | 304 | 15 | GO:0051015 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | ERBB2 ATR TRIO PDGFRA SRC OBSCN GCK IDNK TYK2 PIK3R4 PIP5KL1 FES PPP1R9B CDC42BPG CDC42BPA RET TEK YES1 MAP3K6 CDC42BPB TKFC TIE1 EGFR MTOR ROCK1 MAPK1 MAPK4 EPHA3 | 4.41e-06 | 709 | 304 | 28 | GO:0016773 |
| GeneOntologyMolecularFunction | kinase activity | ERBB2 ATR TRIO PDGFRA SRC OBSCN GCK IDNK TYK2 PIK3R4 PIP5KL1 FES PPP1R9B CDC42BPG CDC42BPA RET TEK YES1 MAP3K6 CDC42BPB TKFC TIE1 EGFR MTOR ROCK1 MAPK1 MAPK4 PALS2 EPHA3 | 6.34e-06 | 764 | 304 | 29 | GO:0016301 |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 1.41e-05 | 145 | 304 | 11 | GO:0004713 | |
| GeneOntologyMolecularFunction | protein kinase activity | ERBB2 ATR TRIO PDGFRA SRC OBSCN TYK2 PIK3R4 FES PPP1R9B CDC42BPG CDC42BPA RET TEK YES1 MAP3K6 CDC42BPB TIE1 EGFR MTOR ROCK1 MAPK1 MAPK4 EPHA3 | 1.77e-05 | 600 | 304 | 24 | GO:0004672 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYO6 SPTAN1 SPTB SPTBN2 OBSCN ACTN3 DYSF MEFV SPTBN5 NEFH ANKRD2 FES PPP1R9B JAKMIP1 DMD FMNL1 TBCD ESPN DIP2B ANK2 RHBG MYH7B SLC26A5 DPYSL4 CRK SPTBN4 B9D2 GAS2L1 EGFR MYH14 MYH15 ROCK1 CEP295 DAAM1 ARHGEF2 | 3.04e-05 | 1099 | 304 | 35 | GO:0008092 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 3.07e-05 | 130 | 304 | 10 | GO:0005200 | |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 EPPK1 SPTAN1 SPTB SPTBN2 OBSCN EMILIN3 ERVK-7 ACTN3 NEFH PXDN ANKRD2 ERVK-19 ERVK-25 DMD H2BW2 HSPB2 HSPG2 COL6A3 ANK2 COL6A6 DSP LAMB2 VPS25 SEC31B EMILIN1 SPTBN4 INA LMNA ERVK-8 | 4.27e-05 | 891 | 304 | 30 | GO:0005198 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 5.79e-05 | 65 | 304 | 7 | GO:0004714 | |
| GeneOntologyMolecularFunction | spectrin binding | 1.53e-04 | 34 | 304 | 5 | GO:0030507 | |
| GeneOntologyMolecularFunction | calmodulin binding | MYO6 SPTAN1 OBSCN TRPV6 FBXL2 ORAI1 SLC8A2 EGFR MYH14 IQCB1 MYH15 TRPV5 | 2.23e-04 | 230 | 304 | 12 | GO:0005516 |
| GeneOntologyMolecularFunction | cytidylate cyclase activity | 2.31e-04 | 2 | 304 | 2 | GO:0047805 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 2.31e-04 | 37 | 304 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 2.63e-04 | 38 | 304 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 3.17e-04 | 85 | 304 | 7 | GO:0019199 | |
| GeneOntologyMolecularFunction | ankyrin binding | 3.71e-04 | 23 | 304 | 4 | GO:0030506 | |
| GeneOntologyMolecularFunction | actin binding | MYO6 SPTAN1 SPTB SPTBN2 ACTN3 MEFV SPTBN5 PPP1R9B DMD FMNL1 ESPN MYH7B SPTBN4 GAS2L1 EGFR MYH14 MYH15 DAAM1 | 4.25e-04 | 479 | 304 | 18 | GO:0003779 |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 5.18e-04 | 25 | 304 | 4 | GO:0016849 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 5.27e-04 | 11 | 304 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic intermediate filament cytoskeleton | 6.86e-04 | 3 | 304 | 2 | GO:0099184 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | DCAF6 GAS6 KDM3B ACTN3 SRCAP BCOR MEN1 NEFH ARID1B TRIM11 SARS1 TAB1 FBXL2 USP15 ANAPC7 TNS3 CARM1 ATN1 ANK2 PRAMEF22 CHD1L SH2D2A ECPAS SKI EMILIN1 CRK PEX26 SPTBN4 FEM1B GAS2L1 ZZZ3 MYH14 IQCB1 PDE4DIP ROPN1B NOS1AP | 8.14e-04 | 1356 | 304 | 36 | GO:0060090 |
| GeneOntologyMolecularFunction | protein kinase binding | ERBB2 PIWIL1 SRC TRIM49C GAS6 NEFH ANKRD2 FBXW5 PKD1 TAB1 TRIM49 ATN1 ANK2 DSP NSF APBA1 SKI CRK EGFR MTOR CSPG4 CDK5RAP1 MAPK1 MAPK4 TRIM49B NOS1AP | 9.00e-04 | 873 | 304 | 26 | GO:0019901 |
| GeneOntologyMolecularFunction | kinase binding | ERBB2 PIWIL1 SRC TRIM49C GAS6 NEFH ANKRD2 FBXW5 PKD1 PPP1R9B TAB1 JAKMIP1 TRIM49 ATN1 ANK2 DSP NSF APBA1 SKI CRK EGFR MTOR CSPG4 CDK5RAP1 MAPK1 MAPK4 TRIM49B NOS1AP | 9.10e-04 | 969 | 304 | 28 | GO:0019900 |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 1.12e-03 | 14 | 304 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 1.32e-03 | 172 | 304 | 9 | GO:0044325 | |
| GeneOntologyMolecularFunction | volume-sensitive chloride channel activity | 1.36e-03 | 4 | 304 | 2 | GO:0072320 | |
| GeneOntologyMolecularFunction | lactoperoxidase activity | 1.36e-03 | 4 | 304 | 2 | GO:0140825 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | NES PDGFRA SPTAN1 SPTB SPTBN2 DYSF SPTBN5 RHPN1 PKD1 FES GPSM2 PLXNB1 TBCD ESPN HAUS5 APOA1 CRK SPTBN4 GAS2L1 ARHGAP6 MTOR PDE4DIP ROCK1 CEP295 MAPK1 ARHGEF2 EPHA3 | 1.31e-07 | 579 | 302 | 27 | GO:0051493 |
| GeneOntologyBiologicalProcess | cell junction organization | ERBB2 GRIPAP1 MYO6 SPTB LRFN3 SPTBN2 SRC ACTN3 RHPN1 NEFH NRXN3 AJM1 AGT PPP1R9B PLXNB1 TBCD DOCK1 WHRN LRFN1 ANK2 PCDHGC4 DSP LAMB2 ADGRL1 PPFIA3 TEK CRK SPTBN4 ARHGAP6 SLC8A2 TENM4 INA ROCK1 PCDHGC3 EPHA3 NOS1AP | 3.34e-07 | 974 | 302 | 36 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | RABEP2 NES ATR PDGFRA RTEL1 SPTAN1 SPTB SPTBN2 SRC TMEM135 DYSF BID SPTBN5 RHPN1 BMP7 ARID1B NCAPG FBXW5 PKD1 FES GPSM2 ANAPC7 PLXNB1 TBCD ANAPC4 ESPN LRFN1 SYT3 HAUS5 APOA1 HUWE1 CRK SPTBN4 GAS2L1 ARHGAP6 LMNA MTOR PDE4DIP ROCK1 CEP295 MAPK1 ARHGEF2 EPHA3 NSMCE4A | 4.23e-07 | 1342 | 302 | 44 | GO:0033043 |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | RTEL1 CYTH2 SPTAN1 SPTB SPTBN2 SRC DYSF MEFV LRIG2 SPTBN5 RHPN1 BMP7 TRIM11 FBXL2 TBCD ESPN CARM1 DIP2B HSPG2 RTN4RL1 APOA1 HUWE1 EMILIN1 SPTBN4 GAS2L1 ARHGAP6 LMNA MTOR CSPG4 ROCK1 ARHGEF2 RTN4RL2 EPHA3 | 5.20e-07 | 864 | 302 | 33 | GO:0051129 |
| GeneOntologyBiologicalProcess | actin filament-based process | PDGFRA MYO6 CYTH2 SPTAN1 SPTB SPTBN2 SRC OBSCN ACTN3 SPTBN5 RHPN1 PPP1R9B FMNL1 ESPN CDC42BPG CDC42BPA ANK2 DSP MYH7B APOA1 CDC42BPB CRK SPTBN4 GAS2L1 ARHGAP6 MYH14 RANGRF MTOR ROCK1 DAAM1 ARHGEF2 EPHA3 NOS1AP | 1.71e-06 | 912 | 302 | 33 | GO:0030029 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | TTYH1 SRC GAS6 ACTN3 ITGB7 MEN1 RHPN1 AGT PKD1 DMD TBCD DOCK1 LAMB2 APOA1 TEK EMILIN1 CRK ARHGAP6 ROCK1 EPHA3 | 2.98e-06 | 410 | 302 | 20 | GO:0031589 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | RABEP2 ATR RTEL1 SPTAN1 SPTB LRFN3 SPTBN2 SRC MEFV BID SPTBN5 RHPN1 BMP7 TRIM11 AGT FES GPSM2 PPP1R9B FBXL2 TBCD DOCK1 ESPN LRFN1 HAUS5 ADGRL1 APOA1 TEK EMILIN1 SPTBN4 ARHGAP6 TIE1 MTOR PDE4DIP TLR4 ROCK1 CEP295 ARHGEF2 EPHA3 | 5.15e-06 | 1189 | 302 | 38 | GO:0044087 |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | SPTAN1 SPTB SPTBN2 DYSF SPTBN5 RHPN1 TBCD HSPG2 EMILIN1 SPTBN4 GAS2L1 ARHGAP6 ARHGEF2 | 7.15e-06 | 197 | 302 | 13 | GO:1902904 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | PDGFRA MYO6 CYTH2 SPTAN1 SPTB SPTBN2 SRC OBSCN ACTN3 SPTBN5 RHPN1 PPP1R9B FMNL1 ESPN CDC42BPG CDC42BPA APOA1 CDC42BPB CRK SPTBN4 GAS2L1 ARHGAP6 MYH14 MTOR ROCK1 DAAM1 ARHGEF2 EPHA3 NOS1AP | 7.81e-06 | 803 | 302 | 29 | GO:0030036 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | ADAMTS19 EPPK1 PDGFRA MYO6 SPTAN1 SPTB SPTBN2 SRC OBSCN DYSF BID SPTBN5 RHPN1 NEFH PXDN FES PPP1R9B TBCD ESPN HSPG2 DSP HAUS5 APOA1 EMILIN1 SPTBN4 GAS2L1 ARHGAP6 INA MTOR PDE4DIP ROCK1 ARHGEF2 | 1.25e-05 | 957 | 302 | 32 | GO:0097435 |
| GeneOntologyBiologicalProcess | nitric oxide-cGMP-mediated signaling | 1.37e-05 | 11 | 302 | 4 | GO:0038060 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | ERBB2 CYTH2 LRFN3 LRRC32 SRC DYSF MEN1 TYK2 BMP7 ARID1B PKD1 FES DMD ALOX12 PLXNB1 TBCD DOCK1 HSPG2 LAMB2 APOA1 RET TEK YES1 EMILIN1 CRK ARHGAP6 MTOR ASCL2 B4GALNT2 ROCK1 EPHA3 | 1.71e-05 | 927 | 302 | 31 | GO:0030155 |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | ERBB2 ATR PDGFRA SRC AGT PKD1 FES DMD TTLL10 CARM1 CDC42BPG DIP2B P4HA2 CDC42BPA APOA1 VPS25 RET TEK YES1 CDC42BPB SPTBN4 P4HTM EGFR MTOR CSPG4 TLR4 ROCK1 MAPK1 ARHGEF2 EPHA3 NOS1AP NSMCE4A | 1.84e-05 | 976 | 302 | 32 | GO:0018193 |
| GeneOntologyBiologicalProcess | heart development | ADAMTS19 ERBB2 PDGFRA BCOR TBC1D32 BMP7 ZFP36L1 AGT ARL13B PKD1 FES TAB1 DNAH5 HSPG2 ANK2 DSP SKI TEK EMILIN1 TENM4 LMNA TIE1 EGFR MTOR ROCK1 MAPK1 EPHA3 | 2.03e-05 | 757 | 302 | 27 | GO:0007507 |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | ERBB2 TRIO CYTH2 GAS6 CHAD BCOR MEN1 LRIG2 BMP7 TRIM11 SARS1 ZFP36L1 ANKRD2 AGT DMD CARM1 DIP2B HSPG2 VASN PRAMEF22 RTN4RL1 HUWE1 SKI SKIL TEK EMILIN1 USP2 LMNA TIE1 EGFR ASCL2 IQCB1 TLR4 ANKRD17 ROCK1 MAPK1 ARHGEF2 | 2.20e-05 | 1220 | 302 | 37 | GO:0051093 |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 2.41e-05 | 105 | 302 | 9 | GO:1901879 | |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | SPTAN1 SPTB SPTBN2 DYSF SPTBN5 RHPN1 FES TBCD HSPG2 HAUS5 APOA1 EMILIN1 SPTBN4 GAS2L1 ARHGAP6 MTOR PDE4DIP ROCK1 ARHGEF2 | 2.74e-05 | 438 | 302 | 19 | GO:1902903 |
| GeneOntologyBiologicalProcess | synapse organization | ERBB2 GRIPAP1 MYO6 SPTB LRFN3 SPTBN2 NEFH NRXN3 PPP1R9B PLXNB1 DOCK1 LRFN1 PCDHGC4 LAMB2 ADGRL1 PPFIA3 CRK SPTBN4 SLC8A2 TENM4 INA ROCK1 PCDHGC3 EPHA3 NOS1AP | 2.85e-05 | 685 | 302 | 25 | GO:0050808 |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | ERBB2 DYSF NEFH FBXW5 PKD1 FES GPSM2 TBCD HAUS5 GAS2L1 PDE4DIP ROCK1 CEP295 ARHGEF2 EPHA3 | 3.00e-05 | 293 | 302 | 15 | GO:0032886 |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | SPTAN1 SPTB SPTBN2 DYSF SPTBN5 RHPN1 TBCD ESPN SPTBN4 GAS2L1 ARHGAP6 ARHGEF2 | 3.06e-05 | 194 | 302 | 12 | GO:0051494 |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 4.87e-05 | 89 | 302 | 8 | GO:1901880 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex assembly | SPTAN1 SPTB SPTBN2 SRC MEFV SPTBN5 TRIM11 FBXL2 TBCD SPTBN4 ARHGEF2 | 5.09e-05 | 173 | 302 | 11 | GO:0031333 |
| GeneOntologyBiologicalProcess | protein depolymerization | NES SPTAN1 SPTB SPTBN2 DYSF SPTBN5 PPP1R9B SPTBN4 GAS2L1 ARHGEF2 | 5.32e-05 | 144 | 302 | 10 | GO:0051261 |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | RTEL1 SPTAN1 SPTB SPTBN2 SRC DYSF SPTBN5 RHPN1 BMP7 TBCD ESPN HUWE1 SPTBN4 GAS2L1 ARHGAP6 LMNA MTOR ARHGEF2 | 5.36e-05 | 421 | 302 | 18 | GO:0010639 |
| GeneOntologyBiologicalProcess | regulation of microtubule cytoskeleton organization | DYSF PKD1 FES GPSM2 TBCD HAUS5 GAS2L1 PDE4DIP ROCK1 ARHGEF2 EPHA3 | 5.95e-05 | 176 | 302 | 11 | GO:0070507 |
| GeneOntologyBiologicalProcess | cellular response to osmotic stress | 8.78e-05 | 72 | 302 | 7 | GO:0071470 | |
| GeneOntologyBiologicalProcess | regeneration | EPPK1 GAS6 DYSF LRIG2 NEFH DMD HSPG2 LAMB2 RTN4RL1 APOA1 EGFR B4GALNT2 RTN4RL2 | 9.40e-05 | 252 | 302 | 13 | GO:0031099 |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 1.12e-04 | 100 | 302 | 8 | GO:0043242 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | TTYH1 ERBB2 PDGFRA LRFN3 LRRC32 SRC ITGB7 TYK2 BMP7 ARID1B NRXN3 ZFP36L1 PKD1 ALOX12 PCDHGC4 DSP ADGRL1 APOA1 RET TEK YES1 EMILIN1 TENM4 EGFR ARVCF MTOR ASCL2 B4GALNT2 ROCK1 ROPN1B PCDHGC3 EPHA3 | 1.19e-04 | 1077 | 302 | 32 | GO:0098609 |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic pattern recognition receptor signaling pathway | 1.21e-04 | 129 | 302 | 9 | GO:0039531 | |
| GeneOntologyBiologicalProcess | protein localization to M-band | 2.14e-04 | 2 | 302 | 2 | GO:0036309 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by soluble gas, modulating synaptic transmission | 2.14e-04 | 2 | 302 | 2 | GO:0099554 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by nitric oxide, modulating synaptic transmission | 2.14e-04 | 2 | 302 | 2 | GO:0099555 | |
| GeneOntologyBiologicalProcess | extracellular matrix assembly | 2.20e-04 | 59 | 302 | 6 | GO:0085029 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | PDGFRA SRC OBSCN RHPN1 CDC42BPG CDC42BPA APOA1 CDC42BPB ARHGAP6 MYH14 MTOR ROCK1 | 2.23e-04 | 239 | 302 | 12 | GO:0031032 |
| GeneOntologyBiologicalProcess | muscle tissue development | PDGFRA ACTN3 DYSF CHRND BMP7 ANKRD2 AGT FES DMD HSPG2 DSP SKI SKIL USP2 TENM4 LMNA MYH14 MTOR B4GALNT2 MAPK1 | 2.30e-04 | 558 | 302 | 20 | GO:0060537 |
| GeneOntologyBiologicalProcess | regulation of membrane potential | SRC TMEM135 CHRND BID KCNC2 AGT PIP5KL1 DMD ALOX12 ANK2 DSP SLC26A5 KCNK13 KCNK12 SLC8A2 MYH14 RANGRF MTOR SLC4A11 NOS1AP | 2.35e-04 | 559 | 302 | 20 | GO:0042391 |
| GeneOntologyBiologicalProcess | response to osmotic stress | 2.61e-04 | 113 | 302 | 8 | GO:0006970 | |
| GeneOntologyBiologicalProcess | response to growth factor | ERBB2 PDGFRA LRRC32 SRC GAS6 MEN1 BMP7 KCNC2 ZFP36L1 AGT PPP1R9B TAB1 DMD USP15 VASN FBXL15 APOA1 SKI SKIL TEK YES1 EMILIN1 CRK EGFR TLR4 ROCK1 MAPK1 | 2.64e-04 | 883 | 302 | 27 | GO:0070848 |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | PDGFRA SPTAN1 SPTB SPTBN2 SPTBN5 RHPN1 ANK2 DSP MYH7B APOA1 CRK SPTBN4 ARHGAP6 RANGRF MTOR ROCK1 EPHA3 | 2.72e-04 | 438 | 302 | 17 | GO:0032970 |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 2.78e-04 | 144 | 302 | 9 | GO:0043244 | |
| GeneOntologyBiologicalProcess | cell junction assembly | MYO6 LRFN3 SPTBN2 SRC ACTN3 RHPN1 NRXN3 AGT PPP1R9B PLXNB1 TBCD DOCK1 LRFN1 ANK2 ADGRL1 TEK CRK ARHGAP6 ROCK1 EPHA3 | 2.96e-04 | 569 | 302 | 20 | GO:0034329 |
| GeneOntologyBiologicalProcess | neuron projection development | ERBB2 TRIO MYO6 CYTH2 LRIG2 NEFH BMP7 ARID1B NRXN3 AGT FES PPP1R9B DMD PLXNB1 CARM1 WHRN DIP2B HSPG2 SYT3 LAMB2 RTN4RL1 APOA1 RET SKIL CRK SPTBN4 ARHGEF40 EGFR MTOR CSPG4 KIAA1755 BLOC1S3 ROCK1 RTN4RL2 EPHA3 | 3.02e-04 | 1285 | 302 | 35 | GO:0031175 |
| GeneOntologyBiologicalProcess | positive regulation of extrinsic apoptotic signaling pathway | 3.16e-04 | 63 | 302 | 6 | GO:2001238 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex assembly | ATR SPTAN1 SPTB SPTBN2 SRC MEFV BID SPTBN5 TRIM11 FES FBXL2 TBCD HAUS5 SPTBN4 MTOR PDE4DIP TLR4 ARHGEF2 | 3.43e-04 | 489 | 302 | 18 | GO:0043254 |
| GeneOntologyBiologicalProcess | regulation of extrinsic apoptotic signaling pathway | 3.49e-04 | 181 | 302 | 10 | GO:2001236 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | NES ERBB2 TRIO SRC RHPN1 NEFH BMP7 NRXN3 ARL13B FES DMD FMNL1 CFAP410 PLXNB1 TBCD WHRN DIP2B HSPG2 SYT3 SLC26A5 LAMB2 RTN4RL1 RET SKIL CRK SPTBN4 ARHGEF40 EGFR MYH14 KIAA1755 ROCK1 ARHGEF2 EPHA3 | 3.50e-04 | 1194 | 302 | 33 | GO:0000902 |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine phosphorylation | ERBB2 PDGFRA SRC AGT FES VPS25 TEK YES1 EGFR MTOR CSPG4 TLR4 ARHGEF2 EPHA3 | 3.55e-04 | 327 | 302 | 14 | GO:0018108 |
| GeneOntologyBiologicalProcess | striated muscle contraction | ACTN3 CHRND DMD ANK2 DSP MYH7B DTNA MYH14 RANGRF MTOR NOS1AP | 3.74e-04 | 217 | 302 | 11 | GO:0006941 |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine modification | ERBB2 PDGFRA SRC AGT FES VPS25 TEK YES1 EGFR MTOR CSPG4 TLR4 ARHGEF2 EPHA3 | 3.78e-04 | 329 | 302 | 14 | GO:0018212 |
| GeneOntologyBiologicalProcess | regulation of cell-substrate adhesion | SRC MEN1 DMD TBCD DOCK1 APOA1 TEK EMILIN1 CRK ARHGAP6 ROCK1 EPHA3 | 3.89e-04 | 254 | 302 | 12 | GO:0010810 |
| GeneOntologyBiologicalProcess | positive regulation of small GTPase mediated signal transduction | 4.07e-04 | 92 | 302 | 7 | GO:0051057 | |
| GeneOntologyBiologicalProcess | actin filament depolymerization | 4.07e-04 | 66 | 302 | 6 | GO:0030042 | |
| GeneOntologyBiologicalProcess | neuron development | ERBB2 TRIO MYO6 CYTH2 LRIG2 NEFH BMP7 ARID1B NRXN3 AGT FES PPP1R9B DMD SCLT1 PLXNB1 TBCD CARM1 WHRN DIP2B HSPG2 SYT3 LAMB2 RTN4RL1 APOA1 RET SKIL CRK SPTBN4 ARHGEF40 TENM4 EGFR MTOR CSPG4 KIAA1755 BLOC1S3 ROCK1 RTN4RL2 EPHA3 | 4.18e-04 | 1463 | 302 | 38 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | ERBB2 TRIO CYTH2 SRC OBSCN PLXNB1 TNS3 CDC42BPA APOA1 TEK CRK ARHGAP6 ARHGEF40 ARHGEF2 | 4.26e-04 | 333 | 302 | 14 | GO:0051056 |
| GeneOntologyBiologicalProcess | cytoplasmic pattern recognition receptor signaling pathway | 4.71e-04 | 188 | 302 | 10 | GO:0002753 | |
| GeneOntologyBiologicalProcess | axon regeneration | 5.18e-04 | 69 | 302 | 6 | GO:0031103 | |
| GeneOntologyBiologicalProcess | glial cell development | 5.24e-04 | 157 | 302 | 9 | GO:0021782 | |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | NHLRC1 ERBB2 GRIPAP1 GAS6 NRXN3 ARL13B GPSM2 PPP1R9B ANK2 NSF BLZF1 SPTBN4 EGFR RANGRF ROCK1 EPHA3 | 5.29e-04 | 422 | 302 | 16 | GO:1990778 |
| GeneOntologyBiologicalProcess | actin filament capping | 5.46e-04 | 46 | 302 | 5 | GO:0051693 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol 3-kinase/protein kinase B signal transduction | ERBB2 PDGFRA SRC GAS6 OBSCN PIK3R4 ZFP36L1 AGT FBXL2 PLXNB1 COL6A3 RET TEK EGFR MTOR | 5.48e-04 | 382 | 302 | 15 | GO:0043491 |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | NHLRC1 ERBB2 PDGFRA SRC GAS6 GCK MEN1 BMP7 TRIM11 AGT PIP5KL1 PPP1R9B TAB1 DMD APOA1 VPS25 RET TEK YES1 SPTBN4 SLC8A2 TIE1 EGFR MTOR CSPG4 TLR4 CDK5RAP1 ROCK1 ROPN1B MAPK1 ARHGEF2 DHX34 ROPN1 | 5.56e-04 | 1226 | 302 | 33 | GO:0042325 |
| GeneOntologyBiologicalProcess | focal adhesion assembly | 5.62e-04 | 97 | 302 | 7 | GO:0048041 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | LRRC32 SRC MEN1 ZFP36L1 TAB1 USP15 VASN APOA1 SKI SKIL YES1 EMILIN1 CRK ROCK1 | 5.71e-04 | 343 | 302 | 14 | GO:0071559 |
| GeneOntologyBiologicalProcess | peripheral nervous system development | 5.97e-04 | 98 | 302 | 7 | GO:0007422 | |
| GeneOntologyBiologicalProcess | ERBB2 signaling pathway | 6.06e-04 | 27 | 302 | 4 | GO:0038128 | |
| GeneOntologyBiologicalProcess | mannose metabolic process | 6.20e-04 | 12 | 302 | 3 | GO:0006013 | |
| GeneOntologyBiologicalProcess | postsynaptic intermediate filament cytoskeleton organization | 6.35e-04 | 3 | 302 | 2 | GO:0099185 | |
| GeneOntologyBiologicalProcess | regulation of growth plate cartilage chondrocyte proliferation | 6.35e-04 | 3 | 302 | 2 | GO:0003420 | |
| GeneOntologyBiologicalProcess | branching involved in lymph vessel morphogenesis | 6.35e-04 | 3 | 302 | 2 | GO:0060854 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by soluble gas | 6.35e-04 | 3 | 302 | 2 | GO:0099543 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by nitric oxide | 6.35e-04 | 3 | 302 | 2 | GO:0099548 | |
| GeneOntologyBiologicalProcess | regulation of heart rate | 6.35e-04 | 129 | 302 | 8 | GO:0002027 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | SRC ACTN3 ITGB7 RHPN1 AGT PKD1 DMD TEK EMILIN1 ARHGAP6 ROCK1 EPHA3 | 6.68e-04 | 270 | 302 | 12 | GO:0007160 |
| GeneOntologyBiologicalProcess | cardiac conduction | 6.74e-04 | 100 | 302 | 7 | GO:0061337 | |
| GeneOntologyBiologicalProcess | Rho protein signal transduction | 7.18e-04 | 164 | 302 | 9 | GO:0007266 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to osmotic stress | 7.97e-04 | 13 | 302 | 3 | GO:0106049 | |
| GeneOntologyBiologicalProcess | DNA integration | 7.97e-04 | 13 | 302 | 3 | GO:0015074 | |
| GeneOntologyCellularComponent | spectrin | 8.20e-08 | 9 | 309 | 5 | GO:0008091 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYO6 SPTAN1 SPTB SPTBN2 SRC GCK ACTN3 SPTBN5 PPP1R9B TNS3 ESPN WHRN CDC42BPA MYH7B TEK YES1 CDC42BPB CRK SPTBN4 GAS2L1 ARHGAP6 MYH14 MYH15 DAAM1 ARHGEF2 EPHA3 NOS1AP | 1.44e-07 | 576 | 309 | 27 | GO:0015629 |
| GeneOntologyCellularComponent | supramolecular fiber | NES EPPK1 MYO6 SPTAN1 SRC OBSCN GCK ACTN3 DYSF MEFV NEFH ANKRD2 JAKMIP1 DMD TTLL10 DNAH5 TBCD ESPN WHRN COL6A3 ANK2 VMAC DSP MYH7B HAUS5 TEK YES1 SPTBN4 GAS2L1 ARHGAP6 SLC8A2 INA LMNA MYH14 PDE4DIP NINL MYH15 CEP295 ARHGEF2 NOS1AP | 8.35e-07 | 1179 | 309 | 40 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | NES EPPK1 MYO6 SPTAN1 SRC OBSCN GCK ACTN3 DYSF MEFV NEFH ANKRD2 JAKMIP1 DMD TTLL10 DNAH5 TBCD ESPN WHRN COL6A3 ANK2 VMAC DSP MYH7B HAUS5 TEK YES1 SPTBN4 GAS2L1 ARHGAP6 SLC8A2 INA LMNA MYH14 PDE4DIP NINL MYH15 CEP295 ARHGEF2 NOS1AP | 9.89e-07 | 1187 | 309 | 40 | GO:0099081 |
| GeneOntologyCellularComponent | anchoring junction | DCAF6 EPPK1 CYTH2 SPTAN1 SPTBN2 SRC OBSCN ACTN3 ITGB7 AJM1 FES PPP1R9B DMD TNS3 TBCD ESPN HSPG2 CDC42BPA ATN1 ANK2 DSP TEK YES1 CDC42BPB SPTBN4 EGFR ARVCF RANGRF CSPG4 MAPK1 ARHGEF2 PALS2 PCDHGC3 NOS1AP | 3.38e-06 | 976 | 309 | 34 | GO:0070161 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | NES EPPK1 MYO6 SRC GCK ACTN3 DYSF MEFV NEFH JAKMIP1 DMD TTLL10 DNAH5 TBCD ESPN WHRN VMAC DSP HAUS5 TEK YES1 SPTBN4 GAS2L1 ARHGAP6 SLC8A2 INA LMNA PDE4DIP NINL CEP295 ARHGEF2 | 1.15e-05 | 899 | 309 | 31 | GO:0099513 |
| GeneOntologyCellularComponent | actin filament | 1.15e-05 | 146 | 309 | 11 | GO:0005884 | |
| GeneOntologyCellularComponent | postsynapse | ERBB2 GRIPAP1 ATR TRIO MYO6 CYTH2 SPTAN1 SPTB LRFN3 SPTBN2 SRC CHRND NEFH KCNC2 CPT1C PPP1R9B DMD DOCK1 WHRN LRFN1 ANK2 SYT3 NSF APBA1 YES1 FAM81A SLC8A2 INA MTOR DROSHA MAPK1 ARHGEF2 NOS1AP | 2.08e-05 | 1018 | 309 | 33 | GO:0098794 |
| GeneOntologyCellularComponent | cell cortex | MYO6 SPTAN1 SPTB SPTBN2 GCK ACTN3 SPTBN5 GPSM2 EXOC3L1 PPP1R9B FMNL1 PPFIA3 SPTBN4 PLA2G4C GUCY1B1 PDE4DIP | 1.41e-04 | 371 | 309 | 16 | GO:0005938 |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 2.52e-04 | 9 | 309 | 3 | GO:0014731 | |
| GeneOntologyCellularComponent | ruffle | ERBB2 MYO6 CYTH2 SRC MEFV PPP1R9B EGFR CSPG4 TLR4 ROCK1 ARHGEF2 | 2.60e-04 | 206 | 309 | 11 | GO:0001726 |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 4.61e-04 | 93 | 309 | 7 | GO:0030864 | |
| GeneOntologyCellularComponent | myosin filament | 4.64e-04 | 25 | 309 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | paranodal junction | 4.83e-04 | 11 | 309 | 3 | GO:0033010 | |
| GeneOntologyCellularComponent | cell leading edge | ERBB2 MYO6 CYTH2 SRC DYSF MEFV KCNC2 PPP1R9B DMD CDC42BPG CDC42BPA ATN1 CDC42BPB EGFR CSPG4 TLR4 ROCK1 ARHGEF2 | 5.01e-04 | 500 | 309 | 18 | GO:0031252 |
| GeneOntologyCellularComponent | intercalated disc | 5.04e-04 | 68 | 309 | 6 | GO:0014704 | |
| GeneOntologyCellularComponent | glutamatergic synapse | GRIPAP1 TRIO MYO6 CYTH2 SPTAN1 SPTB LRFN3 SPTBN2 SRC NRXN3 CPT1C DOCK1 APBA1 ADGRL1 PPFIA3 YES1 FAM81A TENM4 INA GUCY1A1 GUCY1B1 MTOR DROSHA ARHGEF2 NOS1AP | 5.09e-04 | 817 | 309 | 25 | GO:0098978 |
| GeneOntologyCellularComponent | cell cortex region | 5.14e-04 | 45 | 309 | 5 | GO:0099738 | |
| GeneOntologyCellularComponent | postsynaptic specialization | MYO6 CYTH2 LRFN3 SRC CHRND NEFH PPP1R9B DMD LRFN1 ANK2 NSF YES1 FAM81A SLC8A2 INA DROSHA MAPK1 ARHGEF2 | 5.37e-04 | 503 | 309 | 18 | GO:0099572 |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 5.41e-04 | 26 | 309 | 4 | GO:0099571 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 6.76e-04 | 129 | 309 | 8 | GO:0030863 | |
| GeneOntologyCellularComponent | axon | TTYH1 GRIPAP1 PDGFRA MYO6 CYTH2 SPTAN1 LRFN3 SRC LRIG2 NEFH KCNC2 CPT1C PPP1R9B DMD WHRN DIP2B DTNA ADGRL1 RET SPTBN4 ORAI1 SLC8A2 MYH14 BLOC1S3 MAPK1 RTN4RL2 | 7.96e-04 | 891 | 309 | 26 | GO:0030424 |
| GeneOntologyCellularComponent | basolateral plasma membrane | ERBB2 EPPK1 KCNC2 PKD1 ANK2 RHBG DSP SLC26A5 TEK ORAI1 SLC8A2 EGFR SLC4A11 | 1.02e-03 | 320 | 309 | 13 | GO:0016323 |
| GeneOntologyCellularComponent | neurofilament | 1.03e-03 | 14 | 309 | 3 | GO:0005883 | |
| GeneOntologyCellularComponent | postsynaptic intermediate filament cytoskeleton | 1.28e-03 | 4 | 309 | 2 | GO:0099160 | |
| GeneOntologyCellularComponent | guanylate cyclase complex, soluble | 1.28e-03 | 4 | 309 | 2 | GO:0008074 | |
| GeneOntologyCellularComponent | cell-cell junction | EPPK1 CYTH2 SPTAN1 SPTBN2 OBSCN AJM1 PPP1R9B TBCD CDC42BPA ANK2 DSP TEK CDC42BPB SPTBN4 ARVCF RANGRF ARHGEF2 PALS2 PCDHGC3 | 1.35e-03 | 591 | 309 | 19 | GO:0005911 |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 1.41e-03 | 56 | 309 | 5 | GO:0099091 | |
| GeneOntologyCellularComponent | basal part of cell | ERBB2 EPPK1 GCK KCNC2 PKD1 ANK2 RHBG DSP SLC26A5 TEK ORAI1 SLC8A2 EGFR SLC4A11 | 1.59e-03 | 378 | 309 | 14 | GO:0045178 |
| GeneOntologyCellularComponent | extracellular matrix | ADAMTS19 PODNL1 LRRC32 EMILIN3 CHAD LINGO3 LRIG2 BMP7 PXDN AGT HSPG2 COL6A3 COL6A6 VASN LAMB2 RTN4RL1 APOA1 EMILIN1 CSPG4 RTN4RL2 | 1.91e-03 | 656 | 309 | 20 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ADAMTS19 PODNL1 LRRC32 EMILIN3 CHAD LINGO3 LRIG2 BMP7 PXDN AGT HSPG2 COL6A3 COL6A6 VASN LAMB2 RTN4RL1 APOA1 EMILIN1 CSPG4 RTN4RL2 | 1.98e-03 | 658 | 309 | 20 | GO:0030312 |
| GeneOntologyCellularComponent | sperm cytoplasmic droplet | 2.11e-03 | 5 | 309 | 2 | GO:0097598 | |
| GeneOntologyCellularComponent | sarcolemma | 2.14e-03 | 190 | 309 | 9 | GO:0042383 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 2.19e-03 | 90 | 309 | 6 | GO:0016328 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | GRIPAP1 ATR TRIO CYTH2 TYK2 PIK3R4 ANK2 DTNA ARHGEF40 KIAA1755 | 2.32e-03 | 230 | 309 | 10 | GO:0019898 |
| GeneOntologyCellularComponent | basal plasma membrane | ERBB2 EPPK1 KCNC2 PKD1 ANK2 RHBG DSP SLC26A5 TEK ORAI1 SLC8A2 EGFR SLC4A11 | 2.48e-03 | 354 | 309 | 13 | GO:0009925 |
| GeneOntologyCellularComponent | cell-substrate junction | DCAF6 EPPK1 SRC ACTN3 ITGB7 FES DMD TNS3 HSPG2 TEK YES1 EGFR CSPG4 MAPK1 ARHGEF2 | 2.61e-03 | 443 | 309 | 15 | GO:0030055 |
| GeneOntologyCellularComponent | cell-cell contact zone | 2.72e-03 | 94 | 309 | 6 | GO:0044291 | |
| GeneOntologyCellularComponent | actin-based cell projection | TTYH1 ERBB2 PDGFRA MYO6 SRC PPP1R9B DMD ESPN WHRN TEK NOS1AP | 2.98e-03 | 278 | 309 | 11 | GO:0098858 |
| GeneOntologyCellularComponent | podosome | 3.08e-03 | 41 | 309 | 4 | GO:0002102 | |
| MousePheno | abnormal muscle morphology | NHLRC1 ERBB2 MAN2B1 TRIO PDGFRA RTEL1 SPTAN1 SPTB OBSCN ACTN3 DYSF MEN1 MEST ZFP36L1 ANKRD2 AGT PKD1 FES TAB1 DMD DNAH5 DOCK1 HSPG2 COL6A3 DTNA POR OPA3 RET SKI TEK CRK B9D2 LMNA EGFR GUCY1A1 RANGRF MTOR CDK5RAP1 ANKRD17 ROCK1 DAAM1 MAPK1 | 4.48e-07 | 1106 | 235 | 42 | MP:0002108 |
| MousePheno | abnormal cardiac muscle tissue morphology | NHLRC1 ERBB2 SPTAN1 SPTB MEN1 MEST ZFP36L1 PKD1 FES TAB1 DMD DNAH5 HSPG2 DTNA POR OPA3 TEK B9D2 LMNA EGFR GUCY1A1 RANGRF ANKRD17 MAPK1 | 2.61e-06 | 489 | 235 | 24 | MP:0010630 |
| MousePheno | abnormal heart layer morphology | ERBB2 SPTAN1 SPTB MEN1 MEST ZFP36L1 PKD1 FES TAB1 DMD HSPG2 DTNA POR OPA3 TEK B9D2 LMNA TIE1 EGFR RANGRF ANKRD17 MAPK1 | 2.64e-06 | 422 | 235 | 22 | MP:0010545 |
| MousePheno | abnormal heart ventricle morphology | ADAMTS19 ERBB2 PDGFRA RTEL1 MEN1 TYK2 AARS2 ZFP36L1 FBXW5 PKD1 FES TAB1 DMD DNAH5 DOCK1 CARM1 HSPG2 DSP POR OPA3 SKIL TEK CRK B9D2 LMNA EGFR GUCY1A1 RANGRF IQCB1 ANKRD17 DAAM1 PCDHGC3 | 3.64e-06 | 793 | 235 | 32 | MP:0005294 |
| MousePheno | abnormal myocardium layer morphology | ERBB2 SPTAN1 SPTB MEN1 MEST ZFP36L1 PKD1 FES TAB1 DMD HSPG2 DTNA POR OPA3 TEK B9D2 LMNA EGFR RANGRF ANKRD17 MAPK1 | 6.87e-06 | 414 | 235 | 21 | MP:0005329 |
| MousePheno | abnormal myocardial trabeculae morphology | 3.15e-05 | 144 | 235 | 11 | MP:0002189 | |
| MousePheno | dilated esophagus | 4.58e-05 | 5 | 235 | 3 | MP:0004548 | |
| MousePheno | reduced linear vestibular evoked potential | 6.83e-05 | 14 | 235 | 4 | MP:0004814 | |
| MousePheno | absent cochlear nerve compound action potential | 9.04e-05 | 6 | 235 | 3 | MP:0004416 | |
| Domain | Spectrin_repeat | 4.77e-10 | 29 | 300 | 9 | IPR002017 | |
| Domain | L_dom-like | PODNL1 ERBB2 LRFN3 LRRC32 CHAD LINGO3 LRIG2 PXDN PXDNL LRRC26 PKD1 PPP1R37 FBXO33 FBXL2 CFAP410 LRFN1 VASN PRAMEF22 FBXL15 RTN4RL1 EGFR LRRC1 TLR4 RTN4RL2 | 7.13e-10 | 328 | 300 | 24 | IPR032675 |
| Domain | SPEC | 1.28e-09 | 32 | 300 | 9 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.28e-09 | 32 | 300 | 9 | IPR018159 | |
| Domain | Spectrin | 1.61e-09 | 23 | 300 | 8 | PF00435 | |
| Domain | Cys-rich_flank_reg_C | LRFN3 CHAD LINGO3 LRIG2 PXDN PXDNL LRRC26 PKD1 LRFN1 VASN RTN4RL1 TLR4 RTN4RL2 | 1.99e-09 | 90 | 300 | 13 | IPR000483 |
| Domain | LRRCT | LRFN3 CHAD LINGO3 LRIG2 PXDN PXDNL LRRC26 PKD1 LRFN1 VASN RTN4RL1 TLR4 RTN4RL2 | 1.99e-09 | 90 | 300 | 13 | SM00082 |
| Domain | - | PODNL1 LRFN3 LRRC32 CHAD LINGO3 LRIG2 PXDN PXDNL LRRC26 PKD1 PPP1R37 FBXO33 FBXL2 CFAP410 LRFN1 VASN PRAMEF22 FBXL15 RTN4RL1 LRRC1 TLR4 RTN4RL2 | 1.24e-08 | 321 | 300 | 22 | 3.80.10.10 |
| Domain | Leu-rich_rpt | PODNL1 LRFN3 LRRC32 CHAD LINGO3 LRIG2 PXDN PXDNL LRRC26 PKD1 PPP1R37 FBXL2 CFAP410 LRFN1 VASN FBXL15 RTN4RL1 LRRC1 TLR4 RTN4RL2 | 1.69e-08 | 271 | 300 | 20 | IPR001611 |
| Domain | LRR_8 | PODNL1 LRFN3 LRRC32 CHAD LINGO3 LRIG2 PXDN PXDNL LRRC26 PKD1 LRFN1 VASN RTN4RL1 LRRC1 TLR4 RTN4RL2 | 1.74e-08 | 171 | 300 | 16 | PF13855 |
| Domain | Leu-rich_rpt_typical-subtyp | PODNL1 LRFN3 LRRC32 CHAD LINGO3 LRIG2 PXDN PXDNL LRRC26 PKD1 LRFN1 VASN RTN4RL1 LRRC1 TLR4 RTN4RL2 | 2.85e-08 | 177 | 300 | 16 | IPR003591 |
| Domain | LRR_TYP | PODNL1 LRFN3 LRRC32 CHAD LINGO3 LRIG2 PXDN PXDNL LRRC26 PKD1 LRFN1 VASN RTN4RL1 LRRC1 TLR4 RTN4RL2 | 2.85e-08 | 177 | 300 | 16 | SM00369 |
| Domain | PROTEIN_KINASE_TYR | ERBB2 PDGFRA SRC OBSCN TYK2 FES RET TEK YES1 TIE1 EGFR EPHA3 | 5.00e-08 | 97 | 300 | 12 | PS00109 |
| Domain | Tyr_kinase_AS | ERBB2 PDGFRA SRC OBSCN TYK2 FES RET TEK YES1 TIE1 EGFR EPHA3 | 5.00e-08 | 97 | 300 | 12 | IPR008266 |
| Domain | LRRNT | PODNL1 LRFN3 LRRC32 CHAD LINGO3 PXDN PXDNL LRRC26 PKD1 VASN RTN4RL1 RTN4RL2 | 5.62e-08 | 98 | 300 | 12 | SM00013 |
| Domain | LRRNT | PODNL1 LRFN3 LRRC32 CHAD LINGO3 PXDN PXDNL LRRC26 PKD1 VASN RTN4RL1 RTN4RL2 | 5.62e-08 | 98 | 300 | 12 | IPR000372 |
| Domain | Tyr_kinase_cat_dom | 1.63e-07 | 88 | 300 | 11 | IPR020635 | |
| Domain | TyrKc | 1.63e-07 | 88 | 300 | 11 | SM00219 | |
| Domain | LRR_1 | PODNL1 LRFN3 LRRC32 CHAD LINGO3 LRIG2 PXDN PXDNL LRRC26 FBXL2 CFAP410 VASN RTN4RL1 LRRC1 TLR4 RTN4RL2 | 5.38e-07 | 219 | 300 | 16 | PF00560 |
| Domain | LRR | PODNL1 LRRC32 CHAD LINGO3 LRIG2 PXDN PXDNL PKD1 PPP1R37 CFAP410 LRFN1 VASN RTN4RL1 LRRC1 TLR4 | 9.35e-07 | 201 | 300 | 15 | PS51450 |
| Domain | ACTININ_2 | 1.31e-06 | 23 | 300 | 6 | PS00020 | |
| Domain | ACTININ_1 | 1.31e-06 | 23 | 300 | 6 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.31e-06 | 23 | 300 | 6 | IPR001589 | |
| Domain | Pkinase_Tyr | 7.58e-06 | 129 | 300 | 11 | PF07714 | |
| Domain | Kinase-like_dom | ERBB2 ATR TRIO PDGFRA SRC OBSCN TYK2 PIK3R4 FES DMD CDC42BPG CDC42BPA RET TEK YES1 MAP3K6 CDC42BPB TIE1 EGFR MTOR ROCK1 MAPK1 MAPK4 EPHA3 | 7.89e-06 | 542 | 300 | 24 | IPR011009 |
| Domain | Ank_2 | ANKLE1 AGAP11 BCOR SOWAHC CLPB ASB6 ANKRD2 NFKB2 TRPV6 ESPN ANK2 FEM1B ANKRD17 TRPV5 | 1.05e-05 | 215 | 300 | 14 | PF12796 |
| Domain | Protein_kinase_ATP_BS | ERBB2 PDGFRA SRC OBSCN TYK2 FES CDC42BPG CDC42BPA RET TEK YES1 MAP3K6 CDC42BPB TIE1 EGFR ROCK1 MAPK1 MAPK4 EPHA3 | 1.30e-05 | 379 | 300 | 19 | IPR017441 |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.44e-05 | 138 | 300 | 11 | IPR001245 | |
| Domain | Myotonic_dystrophy_kinase_coil | 1.62e-05 | 4 | 300 | 3 | PD011252 | |
| Domain | Myotonic_dystrophy_kinase_coil | 1.62e-05 | 4 | 300 | 3 | IPR014930 | |
| Domain | Spectrin_bsu | 1.62e-05 | 4 | 300 | 3 | IPR016343 | |
| Domain | DMPK_coil | 1.62e-05 | 4 | 300 | 3 | PF08826 | |
| Domain | PROTEIN_KINASE_ATP | ERBB2 TRIO PDGFRA SRC OBSCN TYK2 PIK3R4 FES CDC42BPG CDC42BPA RET TEK YES1 MAP3K6 CDC42BPB TIE1 EGFR ROCK1 MAPK1 MAPK4 EPHA3 | 1.82e-05 | 459 | 300 | 21 | PS00107 |
| Domain | Ank | ANKLE1 AGAP11 BCOR SOWAHC CLPB ASB6 ANKRD2 NFKB2 TRPV6 ESPN ANK2 FEM1B ANKRD17 TRPV5 | 2.03e-05 | 228 | 300 | 14 | PF00023 |
| Domain | HEAT | 3.84e-05 | 58 | 300 | 7 | IPR000357 | |
| Domain | Prot_kinase_dom | ERBB2 TRIO PDGFRA SRC OBSCN TYK2 PIK3R4 FES CDC42BPG CDC42BPA RET TEK YES1 MAP3K6 CDC42BPB TIE1 EGFR ROCK1 MAPK1 MAPK4 EPHA3 | 4.59e-05 | 489 | 300 | 21 | IPR000719 |
| Domain | - | ANKLE1 AGAP11 BCOR SOWAHC CLPB ASB6 ANKRD2 NFKB2 TRPV6 ESPN ANK2 FEM1B ANKRD17 TRPV5 | 5.12e-05 | 248 | 300 | 14 | 1.25.40.20 |
| Domain | PROTEIN_KINASE_DOM | ERBB2 TRIO PDGFRA SRC OBSCN TYK2 PIK3R4 FES CDC42BPG CDC42BPA RET TEK YES1 MAP3K6 CDC42BPB TIE1 EGFR ROCK1 MAPK1 MAPK4 EPHA3 | 5.16e-05 | 493 | 300 | 21 | PS50011 |
| Domain | ANK | ANKLE1 AGAP11 BCOR SOWAHC CLPB ASB6 ANKRD2 NFKB2 TRPV6 ESPN ANK2 FEM1B ANKRD17 TRPV5 | 5.84e-05 | 251 | 300 | 14 | SM00248 |
| Domain | ANK_REPEAT | ANKLE1 AGAP11 BCOR SOWAHC CLPB ASB6 ANKRD2 NFKB2 TRPV6 ESPN ANK2 FEM1B ANKRD17 TRPV5 | 6.36e-05 | 253 | 300 | 14 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | ANKLE1 AGAP11 BCOR SOWAHC CLPB ASB6 ANKRD2 NFKB2 TRPV6 ESPN ANK2 FEM1B ANKRD17 TRPV5 | 6.63e-05 | 254 | 300 | 14 | IPR020683 |
| Domain | ANK_REP_REGION | ANKLE1 AGAP11 BCOR SOWAHC CLPB ASB6 ANKRD2 NFKB2 TRPV6 ESPN ANK2 FEM1B ANKRD17 TRPV5 | 6.63e-05 | 254 | 300 | 14 | PS50297 |
| Domain | SPRY | 7.86e-05 | 87 | 300 | 8 | SM00449 | |
| Domain | CH | 8.07e-05 | 65 | 300 | 7 | SM00033 | |
| Domain | Ankyrin_rpt | ANKLE1 AGAP11 BCOR SOWAHC CLPB ASB6 ANKRD2 NFKB2 TRPV6 ESPN ANK2 FEM1B ANKRD17 TRPV5 | 9.23e-05 | 262 | 300 | 14 | IPR002110 |
| Domain | BBOX | 1.18e-04 | 69 | 300 | 7 | SM00336 | |
| Domain | IQ | 1.26e-04 | 93 | 300 | 8 | PS50096 | |
| Domain | ARM-like | ATR PIK3R4 ARID1B NCAPG TBCD HUWE1 ECPAS MROH6 PELP1 ARVCF MTOR IQCB1 IPO13 DAAM1 | 1.27e-04 | 270 | 300 | 14 | IPR011989 |
| Domain | ARM-type_fold | ATR PIK3R4 NCAPG FMNL1 TBCD DOCK1 HUWE1 ECPAS CWC22 MROH6 PELP1 ARVCF MTOR IQCB1 IPO13 DAAM1 | 1.27e-04 | 339 | 300 | 16 | IPR016024 |
| Domain | CH | 1.30e-04 | 70 | 300 | 7 | PF00307 | |
| Domain | HEAT_REPEAT | 1.30e-04 | 70 | 300 | 7 | PS50077 | |
| Domain | Butyrophylin | 1.30e-04 | 70 | 300 | 7 | IPR003879 | |
| Domain | SPRY | 1.36e-04 | 94 | 300 | 8 | PF00622 | |
| Domain | SPRY_dom | 1.36e-04 | 94 | 300 | 8 | IPR003877 | |
| Domain | Elp3/MiaB/NifB | 1.37e-04 | 7 | 300 | 3 | IPR006638 | |
| Domain | Elp3 | 1.37e-04 | 7 | 300 | 3 | SM00729 | |
| Domain | - | 1.42e-04 | 71 | 300 | 7 | 1.10.418.10 | |
| Domain | - | 1.42e-04 | 71 | 300 | 7 | 4.10.45.10 | |
| Domain | B30.2/SPRY | 1.46e-04 | 95 | 300 | 8 | IPR001870 | |
| Domain | B302_SPRY | 1.46e-04 | 95 | 300 | 8 | PS50188 | |
| Domain | zf-B_box | 1.55e-04 | 72 | 300 | 7 | PF00643 | |
| Domain | ZF_ZZ_2 | 1.67e-04 | 18 | 300 | 4 | PS50135 | |
| Domain | ZF_ZZ_1 | 1.67e-04 | 18 | 300 | 4 | PS01357 | |
| Domain | ZZ | 1.67e-04 | 18 | 300 | 4 | PF00569 | |
| Domain | CH | 1.69e-04 | 73 | 300 | 7 | PS50021 | |
| Domain | LRRNT | 1.99e-04 | 53 | 300 | 6 | PF01462 | |
| Domain | CH-domain | 2.01e-04 | 75 | 300 | 7 | IPR001715 | |
| Domain | Znf_ZZ | 2.09e-04 | 19 | 300 | 4 | IPR000433 | |
| Domain | ZnF_ZZ | 2.09e-04 | 19 | 300 | 4 | SM00291 | |
| Domain | ConA-like_dom | TRIM49C GAS6 TRIM49D1 MEFV TRIM11 NRXN3 TRIM49 HSPG2 TRIM39 CSPG4 SPRYD3 TRIM49B | 2.31e-04 | 219 | 300 | 12 | IPR013320 |
| Domain | 2pore_dom_K_chnl_THIK | 2.57e-04 | 2 | 300 | 2 | IPR005410 | |
| Domain | TRPV5/TRPV6 | 2.57e-04 | 2 | 300 | 2 | IPR008344 | |
| Domain | KELK | 2.57e-04 | 2 | 300 | 2 | IPR031597 | |
| Domain | KELK | 2.57e-04 | 2 | 300 | 2 | PF15796 | |
| Domain | ZF_BBOX | 3.00e-04 | 80 | 300 | 7 | PS50119 | |
| Domain | rSAM | 3.21e-04 | 9 | 300 | 3 | IPR007197 | |
| Domain | PH_dom-spectrin-type | 3.21e-04 | 9 | 300 | 3 | IPR001605 | |
| Domain | Radical_SAM | 3.21e-04 | 9 | 300 | 3 | PF04055 | |
| Domain | Znf_B-box | 3.24e-04 | 81 | 300 | 7 | IPR000315 | |
| Domain | MYOSIN_MOTOR | 3.36e-04 | 38 | 300 | 5 | PS51456 | |
| Domain | Myosin_head_motor_dom | 3.36e-04 | 38 | 300 | 5 | IPR001609 | |
| Domain | Myosin_head | 3.36e-04 | 38 | 300 | 5 | PF00063 | |
| Domain | MYSc | 3.36e-04 | 38 | 300 | 5 | SM00242 | |
| Domain | PH | TRIO CYTH2 SPTBN2 OBSCN AGAP11 SPTBN5 CDC42BPG CDC42BPA CDC42BPB SPTBN4 ROCK1 ARHGEF2 | 3.47e-04 | 229 | 300 | 12 | PF00169 |
| Domain | tRNA-bd_arm | 5.38e-04 | 24 | 300 | 4 | IPR010978 | |
| Domain | PH_dom-like | TRIO CYTH2 SPTBN2 OBSCN AGAP11 TYK2 SPTBN5 TNS3 CDC42BPG CDC42BPA APBA1 CDC42BPB SPTBN4 ARHGEF40 ROCK1 ARHGEF2 NOS1AP | 5.63e-04 | 426 | 300 | 17 | IPR011993 |
| Domain | PH | TRIO CYTH2 SPTBN2 OBSCN AGAP11 SPTBN5 CDC42BPG CDC42BPA CDC42BPB SPTBN4 ARHGEF40 ROCK1 ARHGEF2 | 5.90e-04 | 278 | 300 | 13 | SM00233 |
| Domain | PH_DOMAIN | TRIO CYTH2 SPTBN2 OBSCN AGAP11 SPTBN5 CDC42BPG CDC42BPA CDC42BPB SPTBN4 ARHGEF40 ROCK1 ARHGEF2 | 6.10e-04 | 279 | 300 | 13 | PS50003 |
| Domain | DUF1220 | 6.15e-04 | 11 | 300 | 3 | PF06758 | |
| Domain | NBPF_dom | 6.15e-04 | 11 | 300 | 3 | IPR010630 | |
| Domain | NBPF | 6.15e-04 | 11 | 300 | 3 | PS51316 | |
| Domain | Laminin_G_1 | 6.15e-04 | 11 | 300 | 3 | PF00054 | |
| Domain | IQ_motif_EF-hand-BS | 6.16e-04 | 90 | 300 | 7 | IPR000048 | |
| Domain | - | TRIO CYTH2 SPTBN2 OBSCN AGAP11 SPTBN5 TNS3 CDC42BPG CDC42BPA APBA1 CDC42BPB SPTBN4 ARHGEF40 ROCK1 ARHGEF2 NOS1AP | 6.22e-04 | 391 | 300 | 16 | 2.30.29.30 |
| Domain | PH_domain | TRIO CYTH2 SPTBN2 OBSCN AGAP11 SPTBN5 CDC42BPG CDC42BPA CDC42BPB SPTBN4 ARHGEF40 ROCK1 ARHGEF2 | 6.31e-04 | 280 | 300 | 13 | IPR001849 |
| Domain | Tweety | 7.63e-04 | 3 | 300 | 2 | IPR006990 | |
| Domain | Tweety | 7.63e-04 | 3 | 300 | 2 | PF04906 | |
| Domain | - | ATR PIK3R4 ARID1B NCAPG TBCD ECPAS MROH6 ARVCF MTOR IPO13 DAAM1 | 9.63e-04 | 222 | 300 | 11 | 1.25.10.10 |
| Domain | HEAT | 1.01e-03 | 48 | 300 | 5 | PF02985 | |
| Domain | Ig_I-set | 1.03e-03 | 190 | 300 | 10 | IPR013098 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | ERBB2 TRIO SPTAN1 SPTB SPTBN2 SRC SPTBN5 FES PLXNB1 DOCK1 COL6A3 COL6A6 DPYSL4 RET YES1 SPTBN4 EGFR ROCK1 MAPK1 | 3.11e-08 | 261 | 222 | 19 | MM15676 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.09e-07 | 38 | 222 | 8 | MM14969 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 2.19e-07 | 10 | 222 | 5 | MM15112 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 5.73e-07 | 63 | 222 | 9 | M11187 | |
| Pathway | KEGG_FOCAL_ADHESION | ERBB2 PDGFRA SRC CHAD ACTN3 ITGB7 DOCK1 COL6A3 COL6A6 LAMB2 CRK EGFR ROCK1 MAPK1 | 3.22e-06 | 199 | 222 | 14 | M7253 |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 7.55e-06 | 31 | 222 | 6 | M877 | |
| Pathway | WP_FOCAL_ADHESION | ERBB2 PDGFRA SRC CHAD ITGB7 PIK3R4 DOCK1 LAMB2 CRK EGFR ROCK1 MAPK1 MAPK4 | 8.28e-06 | 187 | 222 | 13 | MM15913 |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.09e-05 | 68 | 222 | 8 | MM14968 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | TRIO MYO6 SPTAN1 SRC OBSCN SOWAHC RHPN1 ARL13B FMNL1 PLXNB1 DOCK1 CDC42BPA DSP CDC42BPB ARHGAP6 ARHGEF40 LRRC1 ROCK1 DAAM1 ARHGEF2 | 2.97e-05 | 450 | 222 | 20 | M27078 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | ERBB2 TRIO SPTAN1 PSMA4 SPTB SPTBN2 SRC SPTBN5 FES PLXNB1 DOCK1 COL6A3 ANK2 COL6A6 DPYSL4 RET YES1 SPTBN4 EGFR MYH14 ROCK1 MAPK1 EPHA3 | 3.91e-05 | 575 | 222 | 23 | M29853 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | ERBB2 TRIO SPTAN1 SPTB SPTBN2 SRC SPTBN5 FES PLXNB1 DOCK1 COL6A3 TCF7 COL6A6 DSP DPYSL4 RET YES1 SPTBN4 EGFR ROCK1 MAPK1 | 4.54e-05 | 502 | 222 | 21 | MM14537 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | TRIO MYO6 SPTAN1 SRC OBSCN SOWAHC MEN1 PIK3R4 RHPN1 ARL13B FMNL1 PLXNB1 DOCK1 CDC42BPA DSP CDC42BPB B9D2 ARHGAP6 ARHGEF40 MYH14 LRRC1 ROCK1 DAAM1 MAPK1 ARHGEF2 ROPN1 | 6.75e-05 | 720 | 222 | 26 | M41838 |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 7.73e-05 | 66 | 222 | 7 | MM15925 | |
| Pathway | WP_ERBB_SIGNALING_PATHWAY | 7.89e-05 | 46 | 222 | 6 | MM15950 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 8.08e-05 | 29 | 222 | 5 | M27309 | |
| Pathway | WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING | 8.93e-05 | 47 | 222 | 6 | M39380 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | TRIO MYO6 SPTAN1 SRC OBSCN SOWAHC MEN1 PIK3R4 RHPN1 ARL13B FMNL1 PLXNB1 DOCK1 CDC42BPA DSP CDC42BPB B9D2 ARHGAP6 MYH14 LRRC1 ROCK1 DAAM1 MAPK1 ARHGEF2 | 9.09e-05 | 649 | 222 | 24 | MM15690 |
| Pathway | WP_RAC1PAK1P38MMP2_PATHWAY | 9.37e-05 | 68 | 222 | 7 | M39456 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.24e-04 | 121 | 222 | 9 | M872 | |
| Pathway | PID_NETRIN_PATHWAY | 1.32e-04 | 32 | 222 | 5 | M108 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 1.47e-04 | 73 | 222 | 7 | M638 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | ERBB2 PDGFRA SPTAN1 PSMA4 SPTB SPTBN2 SRC TYK2 SPTBN5 RET TEK SPTBN4 EGFR MAPK1 MAPK4 | 1.58e-04 | 318 | 222 | 15 | MM15278 |
| Pathway | PID_PTP1B_PATHWAY | 1.59e-04 | 52 | 222 | 6 | M50 | |
| Pathway | PID_EPHA_FWDPATHWAY | 1.78e-04 | 34 | 222 | 5 | M177 | |
| Pathway | BIOCARTA_STAT3_PATHWAY | 2.04e-04 | 8 | 222 | 3 | M22063 | |
| Pathway | BIOCARTA_STAT3_PATHWAY | 2.04e-04 | 8 | 222 | 3 | MM1576 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | TRIO MYO6 SPTAN1 OBSCN SOWAHC RHPN1 ARL13B FMNL1 PLXNB1 DOCK1 CDC42BPA DSP CDC42BPB ARHGAP6 LRRC1 ROCK1 DAAM1 ARHGEF2 | 2.06e-04 | 439 | 222 | 18 | MM15595 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | ERBB2 PDGFRA SPTAN1 PSMA4 SPTB SPTBN2 SRC TYK2 SPTBN5 RET TEK SPTBN4 EGFR MAPK1 MAPK4 | 2.14e-04 | 327 | 222 | 15 | M27565 |
| Pathway | WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING | 2.24e-04 | 78 | 222 | 7 | M39824 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 2.38e-04 | 20 | 222 | 4 | M18415 | |
| Pathway | WP_EGFEGFR_SIGNALING | 2.46e-04 | 162 | 222 | 10 | M39334 | |
| Pathway | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | 3.02e-04 | 9 | 222 | 3 | MM15059 | |
| Pathway | WP_FOCAL_ADHESION | ERBB2 PDGFRA SRC CHAD ITGB7 DOCK1 LAMB2 CRK EGFR ROCK1 MAPK1 | 3.18e-04 | 199 | 222 | 11 | M39402 |
| Pathway | WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE | 3.54e-04 | 84 | 222 | 7 | M39839 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 4.19e-04 | 23 | 222 | 4 | M18719 | |
| Pathway | PID_PRL_SIGNALING_EVENTS_PATHWAY | 4.19e-04 | 23 | 222 | 4 | M11 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 4.19e-04 | 23 | 222 | 4 | MM1480 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 4.97e-04 | 24 | 222 | 4 | M2243 | |
| Pathway | WP_ANGIOGENESIS | 4.97e-04 | 24 | 222 | 4 | M39556 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 4.99e-04 | 64 | 222 | 6 | M7923 | |
| Pathway | KEGG_PROSTATE_CANCER | 5.04e-04 | 89 | 222 | 7 | M13191 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 5.79e-04 | 11 | 222 | 3 | MM15046 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 5.84e-04 | 25 | 222 | 4 | M47934 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | TRIO OBSCN SOWAHC RHPN1 ARHGAP6 ARHGEF40 ROCK1 DAAM1 ARHGEF2 | 5.88e-04 | 149 | 222 | 9 | M41805 |
| Pathway | WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS | 5.89e-04 | 66 | 222 | 6 | M39642 | |
| Pathway | WP_IL11_SIGNALING | 6.10e-04 | 44 | 222 | 5 | M39716 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 6.17e-04 | 150 | 222 | 9 | M39520 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 6.78e-04 | 152 | 222 | 9 | MM15834 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 7.63e-04 | 12 | 222 | 3 | M47393 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ERBB2 MGAT4B EPPK1 MAN2B1 TRIO VWA8 OBSCN KDM3B ANKLE1 SRCAP FHIP1B DYSF ACOX3 TYK2 RHPN1 FASN CLCN7 NFKB2 PKD1 TBCD HSPG2 LRFN1 CDC42BPA LAMB2 ADGRL1 HUWE1 CDC42BPB HDDC3 GAS2L1 ORAI1 ARHGEF40 TKFC MROH6 ARVCF MTOR CSPG4 NINL ARHGEF2 DHX34 | 5.66e-13 | 1105 | 316 | 39 | 35748872 |
| Pubmed | NES TRIO MYO6 CYTH2 SPTAN1 SPTB SPTBN2 ACTN3 PIK3R4 NEFH FASN SARS1 AJM1 PPP1R9B DMD DHX29 SLC25A23 VARS1 MOG ANK2 SYT3 DSP NSF POR DPYSL4 ADGRL1 OPA3 PPFIA3 ELP3 CDC42BPB SPTBN4 GAS2L1 SLC8A2 TENM4 INA LMNA ARVCF MYH14 PDE4DIP DDX3Y MAPK1 ARHGEF2 | 2.55e-11 | 1431 | 316 | 42 | 37142655 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | ATR TRIO MYO6 FASN PXDN DOCK1 CDC42BPA DSP ECPAS CDC42BPB ARHGEF40 EGFR MYH14 MTOR ANKRD17 ARHGEF2 | 6.45e-11 | 202 | 316 | 16 | 33005030 |
| Pubmed | RABEP2 NES TRIO CYTH2 SPTAN1 SPTBN2 SRC BCOR LRIG2 NEFH PPP1R9B JAKMIP1 CARM1 DIP2B LRFN1 ANK2 SYT3 NSF DPYSL4 HUWE1 PPFIA3 CDC42BPB FAM81A SPTBN4 INA PELP1 ARVCF MTOR PDE4DIP ANKRD17 ROCK1 MAPK1 ARHGEF2 | 8.42e-11 | 963 | 316 | 33 | 28671696 | |
| Pubmed | RABEP2 TRIO SPTAN1 SPTBN2 BCOR C2CD4C ARID1B TRIM11 NCAPG GANAB CLCN7 ARL13B PPP1R37 PPP1R9B TAB1 FBXO33 DMD TNS3 CDC42BPA DSP DTNA POR VPS25 HUWE1 PPFIA3 ELP3 CDC42BPB EGFR ARVCF LRRC1 ROCK1 MAPK1 ARHGEF2 NOS1AP | 1.85e-10 | 1049 | 316 | 34 | 27880917 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ERBB2 DCAF6 TRIO MYO6 RTEL1 SPTB SRC GAS6 OBSCN TYK2 PXDN ACSF3 PPP1R9B USP15 TBCD DOCK1 ESPN CDC42BPG DIP2B CDC42BPA MAN2B2 DTNA RTN4RL1 ADGRL1 CHD1L HUWE1 ECPAS SKI CDC42BPB SPTBN4 ARHGAP6 TRNT1 EGFR GUCY1A1 MYH14 EEPD1 LRRC1 CDK5RAP1 ANKRD17 DAAM1 PALS2 | 3.07e-10 | 1489 | 316 | 41 | 28611215 |
| Pubmed | 8.73e-10 | 13 | 316 | 6 | 18796539 | ||
| Pubmed | MAN2B1 MYO6 KDM3B ACOX3 ARID1B CLPB PKD1 PPP1R37 PPP1R9B FMNL1 TBCD HSPG2 LAMB2 HUWE1 SKI SKIL YES1 PELP1 BAZ1A DROSHA CSPG4 PDE4DIP ROCK1 DAAM1 | 1.36e-09 | 591 | 316 | 24 | 15231748 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | SPNS1 ATR TRIO PSMA4 SRC GAS6 ACOX3 PIK3R4 CLPB TAB1 ANAPC7 SLC25A23 CFAP410 TNS3 ANAPC4 CARM1 CDC42BPA DTNA RET YES1 MAP3K6 CRK ARHGEF40 GTF2H4 UTP25 EGFR PDE4DIP MYH15 MAPK1 ARHGEF2 | 1.57e-09 | 910 | 316 | 30 | 36736316 |
| Pubmed | ERBB2 TRIO SRC GANAB ARL13B PPP1R37 DMD DTNA ADGRL1 BLZF1 YES1 EGFR ARVCF EEPD1 LRRC1 ROCK1 DAAM1 PALS2 EPHA3 NOS1AP | 2.42e-09 | 421 | 316 | 20 | 36976175 | |
| Pubmed | 4.50e-09 | 83 | 316 | 10 | 11114734 | ||
| Pubmed | WDR33 SPTAN1 SPTBN2 TMEM135 TKTL1 ACTN3 SRCAP MEN1 FASN NRXN3 PXDN PPP1R9B JAKMIP1 DMD ANAPC7 FUBP3 VARS1 ESPN ANK2 PCDHGC4 DSP MYH7B DTNA SKI SPTBN4 TRNT1 INA LMNA MYH14 BAZ1A CSPG4 MYH15 CEP295 ARHGEF2 PCDHGC3 SLC4A11 CFAP46 NSMCE4A | 4.81e-09 | 1442 | 316 | 38 | 35575683 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | SPTBN2 SRC CLCN7 ARL13B PPP1R37 GPSM2 PLXNB1 TNS3 DIP2B CDC42BPA ANK2 DTNA YES1 CDC42BPB INA MROH6 EGFR ARVCF MTOR CSPG4 ROCK1 EPHA3 | 1.62e-08 | 569 | 316 | 22 | 30639242 |
| Pubmed | Identification of tyrosine kinases expressed in the male mouse gubernaculum during development. | 8.22e-08 | 25 | 316 | 6 | 15254900 | |
| Pubmed | Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584. | 9.89e-08 | 6 | 316 | 4 | 8959326 | |
| Pubmed | Spectrins and ankyrinB constitute a specialized paranodal cytoskeleton. | 9.89e-08 | 6 | 316 | 4 | 16687515 | |
| Pubmed | In vivo assembly of the axon initial segment in motor neurons. | 9.89e-08 | 6 | 316 | 4 | 23728480 | |
| Pubmed | GRIPAP1 TRIO VWA8 CYTH2 SPTAN1 AJM1 CPT1C PPP1R9B TAB1 TIMM44 USP15 DHX29 VARS1 CDC42BPA ANK2 DSP DTNA APBA1 POR ADGRL1 HUWE1 PPFIA3 CDC42BPB TENM4 INA LMNA GUCY1B1 PDE4DIP DAAM1 NOS1AP | 2.26e-07 | 1139 | 316 | 30 | 36417873 | |
| Pubmed | 2.29e-07 | 7 | 316 | 4 | 29162624 | ||
| Pubmed | TTYH1 DCAF6 TRIO MYO6 SPTAN1 SPTB SPTBN2 PIK3R4 CLPB ARL13B PKD1 GPSM2 JAKMIP1 WDR17 UAP1L1 VARS1 ANK2 DSP APBA1 HUWE1 SKIL SEC31B CDC42BPB SPTBN4 USP2 P4HTM GUCY1B1 MYH14 DROSHA PDE4DIP PALS2 CCDC24 | 3.04e-07 | 1285 | 316 | 32 | 35914814 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | SPNS1 PSMA4 TYK2 LRIG2 FASN GANAB CLPB TAB1 DMD DHX29 FUBP3 VARS1 TNS3 CARM1 DIP2B NSF DTNA LAMB2 APOA1 HUWE1 ECPAS ELP3 MTOR FLAD1 LRRC1 ANKRD17 MAPK1 | 3.51e-07 | 974 | 316 | 27 | 28675297 |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | NHLRC1 ERBB2 TYK2 ASB6 FBXW5 FES FBXL2 TRIM49 FBXL15 RET YES1 MAP3K6 KBTBD4 TIE1 EGFR MAPK4 | 3.75e-07 | 372 | 316 | 16 | 22939624 |
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 4.67e-07 | 18 | 316 | 5 | 12119179 | |
| Pubmed | ERBB2 DCAF6 VWA8 GAS6 EMILIN3 CRACR2B SRCAP BCOR SOWAHC TYK2 ARID1B ANKRD2 ANAPC7 ANAPC4 ATN1 HAUS5 GPT PPFIA3 SKI SKIL ARHGEF40 ZZZ3 UTP25 DROSHA ANKRD17 CEP295 DHX34 SLC4A11 NOS1AP | 4.79e-07 | 1116 | 316 | 29 | 31753913 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | EPPK1 ATR WDR33 SPTAN1 BID PIK3R4 FASN NCAPG MYO15B ANAPC7 DOCK1 DSP NSF MAGEE2 CHD1L HUWE1 SEC31B LMNA LRRC1 ARHGEF2 | 4.80e-07 | 582 | 316 | 20 | 20467437 |
| Pubmed | 5.19e-07 | 77 | 316 | 8 | 22973453 | ||
| Pubmed | MGAT4B MAN2B1 ATR KDM3B TYK2 PIK3R4 PLXNB1 CDC42BPG DIP2B ATN1 CWC22 MAP3K6 POLR3A ARHGEF40 ARVCF DROSHA CDK5RAP1 ANKRD17 ARHGEF2 DHX34 PCDHGC3 | 6.71e-07 | 650 | 316 | 21 | 38777146 | |
| Pubmed | 7.43e-07 | 3 | 316 | 3 | 19704002 | ||
| Pubmed | 7.43e-07 | 3 | 316 | 3 | 27894083 | ||
| Pubmed | 7.43e-07 | 3 | 316 | 3 | 18211286 | ||
| Pubmed | 7.43e-07 | 3 | 316 | 3 | 22323579 | ||
| Pubmed | 7.43e-07 | 3 | 316 | 3 | 11329183 | ||
| Pubmed | The G-protein regulator LGN modulates the activity of the NO receptor soluble guanylate cyclase. | 7.43e-07 | 3 | 316 | 3 | 22690686 | |
| Pubmed | 7.43e-07 | 3 | 316 | 3 | 24887236 | ||
| Pubmed | NHLRC1 VWA8 CYTH2 ANKLE1 CRACR2B CLPB PXDNL CREB3L3 MOG P4HA2 HAUS5 POR KCNK13 KCNK12 VPS25 MAP3K6 GTF2H4 ZZZ3 PELP1 MTOR EEPD1 NINL DHX34 EPHA3 | 8.03e-07 | 832 | 316 | 24 | 36724073 | |
| Pubmed | DCAF6 TRIO SPTB OBSCN ACTN3 DYSF ARID1B HSPG2 COL6A3 CDC42BPA ANK2 DSP DTNA CDC42BPB LMNA MYH14 DROSHA PDE4DIP | 8.59e-07 | 497 | 316 | 18 | 23414517 | |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 1.35e-06 | 10 | 316 | 4 | 22159418 | |
| Pubmed | 1.59e-06 | 40 | 316 | 6 | 30898150 | ||
| Pubmed | Genetic mutations associated with cigarette smoking in pancreatic cancer. | 1.71e-06 | 63 | 316 | 7 | 19351817 | |
| Pubmed | Brain proteins interacting with the tetramerization region of non-erythroid alpha spectrin. | 2.10e-06 | 11 | 316 | 4 | 17607528 | |
| Pubmed | 2.10e-06 | 11 | 316 | 4 | 31577226 | ||
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 2.10e-06 | 11 | 316 | 4 | 15381706 | |
| Pubmed | TTYH1 NES SPNS1 PDGFRA SRC GAS6 KDM3B FJX1 PIK3R4 LRIG2 RHPN1 MEST BMP7 CLPB FBXW5 PKD1 DTNA TTYH2 DPYSL4 SKIL FEM1B USP2 NKD1 RANGRF PDE4DIP MAPK1 | 2.12e-06 | 1006 | 316 | 26 | 15226823 | |
| Pubmed | RABEP2 MYO6 WDR33 SPTAN1 KDM3B CLPB TAB1 USP15 HSPG2 FBXL15 OPA3 VPS25 HUWE1 YARS2 GTF2H4 DROSHA ARHGEF2 | 2.41e-06 | 481 | 316 | 17 | 28190767 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | EPPK1 MYO6 SPTAN1 PSMA4 ACTN3 MEN1 FASN NCAPG GANAB PXDN AARS2 TNS3 DSP MYH7B HUWE1 LMNA EGFR MYH14 MTOR DAAM1 | 2.43e-06 | 647 | 316 | 20 | 26618866 |
| Pubmed | 2.54e-06 | 162 | 316 | 10 | 25826454 | ||
| Pubmed | Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. | 2.75e-06 | 25 | 316 | 5 | 8493579 | |
| Pubmed | 2.95e-06 | 4 | 316 | 3 | 11919279 | ||
| Pubmed | 2.95e-06 | 4 | 316 | 3 | 16414009 | ||
| Pubmed | 2.95e-06 | 4 | 316 | 3 | 7797556 | ||
| Pubmed | 2.95e-06 | 4 | 316 | 3 | 9701558 | ||
| Pubmed | Plasma membrane-cytoskeleton-endoplasmic reticulum complexes in neurons and astrocytes. | 2.95e-06 | 4 | 316 | 3 | 14593108 | |
| Pubmed | 2.95e-06 | 4 | 316 | 3 | 17631500 | ||
| Pubmed | 2.95e-06 | 4 | 316 | 3 | 10591629 | ||
| Pubmed | 2.95e-06 | 4 | 316 | 3 | 22370483 | ||
| Pubmed | 5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia. | 4.11e-06 | 27 | 316 | 5 | 23027611 | |
| Pubmed | Unconventional myosin VI in the heart: Involvement in cardiac dysfunction progressing with age. | 4.11e-06 | 27 | 316 | 5 | 37169038 | |
| Pubmed | Assessment of a polymorphism of SDK1 with hypertension in Japanese Individuals. | 6.54e-06 | 142 | 316 | 9 | 19851296 | |
| Pubmed | Association of genetic variants with hemorrhagic stroke in Japanese individuals. | 6.92e-06 | 143 | 316 | 9 | 20198315 | |
| Pubmed | 7.33e-06 | 5 | 316 | 3 | 18255094 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 7.33e-06 | 5 | 316 | 3 | 12629516 | |
| Pubmed | 7.33e-06 | 5 | 316 | 3 | 19515834 | ||
| Pubmed | Localization of the membrane-anchored MMP-regulator RECK at the neuromuscular junctions. | 7.33e-06 | 5 | 316 | 3 | 17953659 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NES MYO6 SPTAN1 PSMA4 SRCAP PIK3R4 FASN NCAPG NFKB2 PPP1R37 TIMM44 DHX29 FUBP3 VARS1 TNS3 DSP CHD1L HUWE1 ELP3 POLR3A ARHGEF40 GTF2H4 LMNA ARVCF MYH14 BAZ1A ANKRD17 MAPK1 ARHGEF2 DHX34 | 7.36e-06 | 1353 | 316 | 30 | 29467282 |
| Pubmed | ERBB2 VWA8 KDM3B AGAP11 BCOR ARID1B NRXN3 PLXNB1 CDC42BPA HAUS5 ECPAS CWC22 NINL IPO13 ANKRD17 DAAM1 DHX34 | 8.43e-06 | 529 | 316 | 17 | 14621295 | |
| Pubmed | 8.43e-06 | 15 | 316 | 4 | 33510480 | ||
| Pubmed | 9.10e-06 | 187 | 316 | 10 | 26460568 | ||
| Pubmed | ERBB2 MYO6 PSMA4 FASN GANAB TIMM44 DHX29 DOCK1 CARM1 CDC42BPA ANK2 DSP NSF DTNA ECPAS CRK EGFR ANKRD17 ROCK1 EPHA3 | 9.18e-06 | 708 | 316 | 20 | 39231216 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | TRIO SPTAN1 SPTBN2 SRC AGAP11 PIP5KL1 PPP1R9B ANK2 FAM81A INA MTOR MAPK1 | 1.17e-05 | 281 | 316 | 12 | 28706196 |
| Pubmed | 1.34e-05 | 34 | 316 | 5 | 18848646 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MEN1 TBC1D32 FASN NCAPG AARS2 NFKB2 FBXW5 ANAPC7 FUBP3 VARS1 DSP NSF CHD1L HUWE1 ECPAS SKI SKIL ELP3 PELP1 BAZ1A ANKRD17 ARHGEF2 | 1.45e-05 | 857 | 316 | 22 | 25609649 |
| Pubmed | The transactivated epidermal growth factor receptor recruits Pyk2 to regulate Src kinase activity. | 1.46e-05 | 6 | 316 | 3 | 18667434 | |
| Pubmed | 1.46e-05 | 6 | 316 | 3 | 11797099 | ||
| Pubmed | 1.46e-05 | 6 | 316 | 3 | 12149647 | ||
| Pubmed | 1.46e-05 | 6 | 316 | 3 | 2173144 | ||
| Pubmed | Differential regulation of cell motility and invasion by FAK. | 1.46e-05 | 6 | 316 | 3 | 12615911 | |
| Pubmed | 1.46e-05 | 6 | 316 | 3 | 18439490 | ||
| Pubmed | 1.46e-05 | 6 | 316 | 3 | 15557335 | ||
| Pubmed | 1.46e-05 | 6 | 316 | 3 | 16723512 | ||
| Pubmed | 1.48e-05 | 120 | 316 | 8 | 27320910 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | SPTBN2 OBSCN MYO15B SARS1 PKD1 JAKMIP1 FUBP3 CARM1 CDC42BPG ZNF775 DSP MAGEE2 SH2D2A HUWE1 PPFIA3 ECPAS ZZZ3 LMNA DROSHA CEP295 | 1.60e-05 | 736 | 316 | 20 | 29676528 |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | MYO6 SPTAN1 SPTB NEFH FASN MOG MAN2B2 NSF POR HUWE1 PPFIA3 BLZF1 INA MTOR DDX3Y ROCK1 MAPK1 ARHGEF2 | 1.84e-05 | 621 | 316 | 18 | 22794259 |
| Pubmed | Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. | 1.85e-05 | 18 | 316 | 4 | 8653788 | |
| Pubmed | A quantitative protein interaction network for the ErbB receptors using protein microarrays. | 1.88e-05 | 90 | 316 | 7 | 16273093 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ATR TRIO MYO6 SPTAN1 PSMA4 PIK3R4 FASN NCAPG GANAB SARS1 CLPB TIMM44 DNAH5 DHX29 ANAPC7 FUBP3 VARS1 DSP NSF POR HUWE1 ECPAS CWC22 POLR3A YARS2 LMNA PELP1 MYH14 BAZ1A MTOR | 1.97e-05 | 1425 | 316 | 30 | 30948266 |
| Pubmed | TRIO TAB1 DMD FUBP3 HSPG2 NSF ELP3 TKFC LMNA CDK5RAP1 ANKRD17 ARHGEF2 | 2.09e-05 | 298 | 316 | 12 | 30737378 | |
| Pubmed | TRIO SPTAN1 SPTBN2 NEFH DIP2B ANK2 FAM81A SPTBN4 INA ARVCF MAPK1 | 2.12e-05 | 251 | 316 | 11 | 27507650 | |
| Pubmed | 2.33e-05 | 19 | 316 | 4 | 15024025 | ||
| Pubmed | Identification of a genomic reservoir for new TRIM genes in primate genomes. | 2.33e-05 | 19 | 316 | 4 | 22144910 | |
| Pubmed | Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis. | 2.35e-05 | 38 | 316 | 5 | 18267097 | |
| Pubmed | 2.49e-05 | 94 | 316 | 7 | 32062451 | ||
| Pubmed | 2.53e-05 | 7 | 316 | 3 | 17148612 | ||
| Pubmed | A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk. | 2.53e-05 | 7 | 316 | 3 | 20446891 | |
| Pubmed | 2.53e-05 | 7 | 316 | 3 | 26335717 | ||
| Pubmed | 2.53e-05 | 7 | 316 | 3 | 9632142 | ||
| Pubmed | 2.53e-05 | 7 | 316 | 3 | 22504067 | ||
| Pubmed | 2.53e-05 | 7 | 316 | 3 | 23644655 | ||
| Pubmed | 2.53e-05 | 7 | 316 | 3 | 14636584 | ||
| Pubmed | 2.53e-05 | 7 | 316 | 3 | 12176734 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NES EPPK1 SPTBN2 SRC SRCAP FASN GANAB AARS2 ANAPC7 FUBP3 VARS1 DSP NSF HAUS5 LAMB2 HUWE1 YES1 INA LMNA PELP1 MYH14 BAZ1A MAPK1 ARHGEF2 | 2.60e-05 | 1024 | 316 | 24 | 24711643 |
| Interaction | TOP3B interactions | ERBB2 MGAT4B EPPK1 MAN2B1 TRIO MYO6 VWA8 RTEL1 SPTAN1 SPTB SPTBN2 OBSCN KDM3B ANKLE1 SRCAP FHIP1B DYSF ACOX3 TYK2 RHPN1 FASN CLCN7 NFKB2 PKD1 PPP1R9B FUBP3 TBCD HSPG2 LRFN1 CDC42BPA APBA1 LAMB2 ADGRL1 HUWE1 YES1 CDC42BPB HDDC3 GAS2L1 ORAI1 ARHGEF40 TKFC MROH6 PELP1 ARVCF MTOR CSPG4 NINL ANKRD17 ARHGEF2 DHX34 | 3.53e-08 | 1470 | 301 | 50 | int:TOP3B |
| Interaction | LRRC31 interactions | ATR TRIO MYO6 FASN PXDN DOCK1 CDC42BPA DSP ECPAS CDC42BPB ARHGEF40 EGFR MYH14 MTOR ANKRD17 ARHGEF2 | 8.32e-08 | 205 | 301 | 16 | int:LRRC31 |
| Interaction | GAB1 interactions | ERBB2 SRC ARL13B FES TNS3 DSP SH2D2A RET YES1 CRK EGFR ROCK1 MAPK1 MAPK4 | 4.93e-07 | 178 | 301 | 14 | int:GAB1 |
| Interaction | DLG4 interactions | ERBB2 DCAF6 CYTH2 SRC NEFH GPSM2 PPP1R9B DIP2B LRFN1 ANK2 VMAC NSF APBA1 ADGRL1 HUWE1 YES1 FAM81A TRNT1 INA LRRC1 MAPK1 NOS1AP | 1.21e-06 | 449 | 301 | 22 | int:DLG4 |
| Interaction | DOK1 interactions | 2.58e-06 | 59 | 301 | 8 | int:DOK1 | |
| Interaction | FES interactions | 3.34e-06 | 61 | 301 | 8 | int:FES | |
| Interaction | STAT1 interactions | ERBB2 PDGFRA MYO6 SPTAN1 SPTB SRC BID TYK2 TRIM11 SARS1 TBCD NSF POR HUWE1 USP2 EGFR MYH14 MTOR | 4.32e-06 | 342 | 301 | 18 | int:STAT1 |
| Interaction | TCAP interactions | 8.91e-06 | 50 | 301 | 7 | int:TCAP | |
| Interaction | STAT3 interactions | ERBB2 PDGFRA LRRC32 SRC ARID1B TRIM11 NFKB2 FES TBCD DTNA VASN LAMB2 SH2D2A RET PELP1 EGFR MTOR MAPK1 TRPV5 EPHA3 | 1.38e-05 | 446 | 301 | 20 | int:STAT3 |
| Interaction | USP2 interactions | ERBB2 GRIPAP1 RTEL1 CRACR2B ACTN3 FASN NFKB2 JAKMIP1 USP15 ATN1 TRIM39 USP2 LMNA EGFR | 1.55e-05 | 239 | 301 | 14 | int:USP2 |
| Interaction | RRM2 interactions | ERBB2 PDGFRA SCLT1 ANAPC4 RET KBTBD4 LMNA EGFR MAPK1 PCDHGC3 | 1.61e-05 | 123 | 301 | 10 | int:RRM2 |
| Interaction | GGH interactions | MAN2B1 PDGFRA MYO6 LRFN3 GAS6 LRIG2 NCAPG PXDN PLXNB1 MAN2B2 LAMB2 P4HTM EGFR CSPG4 | 1.87e-05 | 243 | 301 | 14 | int:GGH |
| Interaction | HTR6 interactions | 2.42e-05 | 58 | 301 | 7 | int:HTR6 | |
| Interaction | KCTD13 interactions | NES TRIO MYO6 CYTH2 SPTAN1 SPTB SPTBN2 ACTN3 PIK3R4 NEFH FASN SARS1 AJM1 PPP1R9B DMD DHX29 SLC25A23 VARS1 MOG ANK2 SYT3 DSP NSF POR DPYSL4 ADGRL1 OPA3 PPFIA3 ELP3 CDC42BPB CRK SPTBN4 GAS2L1 SLC8A2 TENM4 INA LMNA ARVCF MYH14 MAPK1 ARHGEF2 | 2.46e-05 | 1394 | 301 | 41 | int:KCTD13 |
| Interaction | RHOB interactions | ERBB2 EPPK1 TRIO MYO6 SPTAN1 SPTBN2 SRC SOWAHC C2CD4C GANAB CLCN7 ARL13B FMNL1 DOCK1 DIP2B CDC42BPA NSF DTNA VASN ADGRL1 YES1 CDC42BPB EGFR ARVCF EEPD1 LRRC1 ROCK1 DAAM1 ARHGEF2 | 2.60e-05 | 840 | 301 | 29 | int:RHOB |
| Interaction | DES interactions | 2.64e-05 | 158 | 301 | 11 | int:DES | |
| Interaction | HSP90AA1 interactions | NHLRC1 NES ERBB2 ATR SPTAN1 SRC MEN1 TYK2 FASN ASB6 AGT FBXW5 FES PPP1R9B TAB1 FBXL2 VARS1 TRIM49 HSPG2 COL6A3 FBXL15 APOA1 HUWE1 RET YES1 MAP3K6 CCIN KBTBD4 INA TTC23 TIE1 EGFR GUCY1B1 MTOR IQCB1 MAPK1 MAPK4 EPHA3 | 3.08e-05 | 1263 | 301 | 38 | int:HSP90AA1 |
| Interaction | RHOH interactions | SPNS1 MYO6 SPTAN1 SPTBN2 MEST GANAB CLCN7 ARL13B FMNL1 CDC42BPA NSF VASN POR YES1 CDC42BPB YARS2 EGFR MTOR ROCK1 DAAM1 NOS1AP | 3.16e-05 | 512 | 301 | 21 | int:RHOH |
| Interaction | ROPN1B interactions | 3.23e-05 | 5 | 301 | 3 | int:ROPN1B | |
| Interaction | BCAR1 interactions | ERBB2 MAN2B1 SRC DYSF LRIG2 PKD1 FES DMD TNS3 DOCK1 P4HA2 HAUS5 YES1 CRK USP2 INA EGFR MTOR FLAD1 CSPG4 ARHGEF2 PALS2 | 3.52e-05 | 556 | 301 | 22 | int:BCAR1 |
| Interaction | PTPRH interactions | 3.68e-05 | 84 | 301 | 8 | int:PTPRH | |
| Interaction | CRKL interactions | ERBB2 PDGFRA TYK2 DOCK1 HUWE1 RET YES1 CRK KBTBD4 LMNA EGFR NINL MAPK1 | 3.95e-05 | 227 | 301 | 13 | int:CRKL |
| Interaction | RHOG interactions | GRIPAP1 TRIO VWA8 SPTAN1 SPTBN2 SOWAHC AARS2 CLCN7 CLPB ARL13B TIMM44 FMNL1 DOCK1 CDC42BPA NSF DTNA VASN POR ADGRL1 BLZF1 YES1 CDC42BPB YARS2 TENM4 EGFR MTOR FLAD1 CDK5RAP1 ROCK1 DAAM1 | 4.41e-05 | 910 | 301 | 30 | int:RHOG |
| Interaction | TNS3 interactions | 4.74e-05 | 87 | 301 | 8 | int:TNS3 | |
| Interaction | ANK3 interactions | PDGFRA SPTAN1 SPTB SPTBN2 PPP1R9B USP15 ANK2 DTNA RET SPTBN4 EGFR ARVCF | 5.23e-05 | 201 | 301 | 12 | int:ANK3 |
| Interaction | TNS2 interactions | ERBB2 ITGB7 DMD VARS1 TNS3 MYH7B DTNA HUWE1 BLZF1 EGFR FLAD1 ROCK1 MAPK1 | 5.64e-05 | 235 | 301 | 13 | int:TNS2 |
| Interaction | DOK2 interactions | 6.19e-05 | 116 | 301 | 9 | int:DOK2 | |
| Interaction | DIAPH1 interactions | 7.09e-05 | 176 | 301 | 11 | int:DIAPH1 | |
| Interaction | C11orf52 interactions | ERBB2 TRIO SPTAN1 SPTBN2 ARL13B DIP2B CDC42BPA DTNA YES1 CDC42BPB EGFR ARVCF PALS2 EPHA3 NOS1AP | 7.39e-05 | 311 | 301 | 15 | int:C11orf52 |
| Interaction | LCK interactions | ERBB2 TRIO MYO6 SPTAN1 SPTBN2 SRC ITGB7 ARL13B VARS1 DIP2B CDC42BPA DSP DTNA SH2D2A YES1 CDC42BPB EGFR MAPK1 NOS1AP | 7.49e-05 | 463 | 301 | 19 | int:LCK |
| Interaction | RHOF interactions | EPPK1 ATR MYO6 SPTAN1 SPTBN2 SOWAHC NCAPG CLCN7 ARL13B FMNL1 TNS3 CDC42BPA NSF VASN POR ADGRL1 ECPAS YES1 CDC42BPB YARS2 EGFR ARVCF MTOR ROCK1 | 8.04e-05 | 673 | 301 | 24 | int:RHOF |
| Interaction | PTK2 interactions | ERBB2 TRIO SRC PKD1 TNS3 DOCK1 SH2D2A RET TEK YES1 CRK EGFR CSPG4 ROCK1 MAPK1 | 8.52e-05 | 315 | 301 | 15 | int:PTK2 |
| Interaction | VSIG4 interactions | SPNS1 ERBB2 LRFN3 SRC SLC25A23 DOCK1 LRFN1 ADGRL1 ECPAS MTOR IPO13 | 8.68e-05 | 180 | 301 | 11 | int:VSIG4 |
| Interaction | CDC16 interactions | RABEP2 BCOR MEN1 FASN USP15 ANAPC7 ANAPC4 HAUS5 SKIL UTP25 EGFR IQCB1 CEP295 | 8.97e-05 | 246 | 301 | 13 | int:CDC16 |
| Interaction | MYCBP2 interactions | NES DCAF6 SPTAN1 SPTBN2 PPP1R9B USP15 CARM1 ANK2 SYT3 HUWE1 PELP1 EGFR GUCY1B1 MTOR SPRYD3 ARHGEF2 | 9.48e-05 | 355 | 301 | 16 | int:MYCBP2 |
| Interaction | IL5RA interactions | 1.04e-04 | 124 | 301 | 9 | int:IL5RA | |
| Interaction | DOK4 interactions | 1.18e-04 | 74 | 301 | 7 | int:DOK4 | |
| Interaction | SHC1 interactions | ERBB2 SPTAN1 SRC FASN PPP1R9B SCLT1 USP15 VARS1 RET TEK YES1 CRK TTC23 EGFR MYH14 MAPK1 | 1.19e-04 | 362 | 301 | 16 | int:SHC1 |
| Interaction | SH2D2A interactions | 1.21e-04 | 52 | 301 | 6 | int:SH2D2A | |
| Interaction | CALB1 interactions | 1.27e-04 | 18 | 301 | 4 | int:CALB1 | |
| Interaction | RHOQ interactions | SPTAN1 SPTBN2 GANAB CLCN7 ARL13B TNS3 CDC42BPG CDC42BPA NSF VASN DPYSL4 YES1 CDC42BPB EGFR MTOR ROCK1 DAAM1 NOS1AP | 1.27e-04 | 442 | 301 | 18 | int:RHOQ |
| Interaction | CBLC interactions | 1.29e-04 | 75 | 301 | 7 | int:CBLC | |
| Interaction | RHOD interactions | ERBB2 MYO6 SPTAN1 SPTB SPTBN2 SOWAHC CLCN7 ARL13B FMNL1 TNS3 CDC42BPA VASN POR ADGRL1 YES1 CDC42BPB YARS2 EGFR MTOR ROCK1 DAAM1 | 1.51e-04 | 572 | 301 | 21 | int:RHOD |
| Interaction | CRABP2 interactions | 1.65e-04 | 78 | 301 | 7 | int:CRABP2 | |
| Interaction | FOXL1 interactions | MYO6 BCOR FASN NCAPG AARS2 VARS1 NSF CHD1L ECPAS MYH14 BAZ1A | 1.84e-04 | 196 | 301 | 11 | int:FOXL1 |
| Interaction | PIK3R2 interactions | ERBB2 PDGFRA FASN FBXL2 LAMB2 RET CRK LMNA EGFR MYH14 NINL EPHA3 | 1.88e-04 | 230 | 301 | 12 | int:PIK3R2 |
| Interaction | CYFIP1 interactions | SPTAN1 SPTBN2 SRC MEN1 NEFH PPP1R9B ANK2 NSF DPYSL4 RET YES1 EGFR ANKRD17 ARHGEF2 | 2.00e-04 | 303 | 301 | 14 | int:CYFIP1 |
| Interaction | SNCA interactions | NES SRC MEST FASN NCAPG PPP1R9B USP15 DHX29 HSPB2 TBCD DIP2B DSP APOA1 ECPAS YES1 CDC42BPB USP2 INA PELP1 EGFR PDE4DIP CEP295 MAPK1 NOS1AP | 2.05e-04 | 716 | 301 | 24 | int:SNCA |
| Interaction | DAB1 interactions | 2.05e-04 | 107 | 301 | 8 | int:DAB1 | |
| Interaction | MAPK8IP1 interactions | 2.23e-04 | 58 | 301 | 6 | int:MAPK8IP1 | |
| Interaction | TBCK interactions | 2.26e-04 | 82 | 301 | 7 | int:TBCK | |
| Interaction | BECN1 interactions | NHLRC1 ERBB2 PDGFRA MEFV PIK3R4 USP15 ATN1 YES1 EGFR MTOR TLR4 | 2.29e-04 | 201 | 301 | 11 | int:BECN1 |
| Interaction | CAV1 interactions | ERBB2 TRIO PDGFRA MYO6 SPTAN1 SPTBN2 SRC C2CD4C BID FASN SARS1 CLCN7 ARL13B ALDH1A3 CDC42BPA DTNA TEK YES1 LMNA EGFR ARVCF LRRC1 TLR4 MAPK1 | 2.41e-04 | 724 | 301 | 24 | int:CAV1 |
| Interaction | PLA2G2A interactions | 2.41e-04 | 38 | 301 | 5 | int:PLA2G2A | |
| Interaction | RND3 interactions | MYO6 SPTAN1 SPTBN2 SRC GANAB PLXNB1 CDC42BPA DSP YES1 CDC42BPB EGFR ROCK1 NOS1AP | 2.51e-04 | 273 | 301 | 13 | int:RND3 |
| Cytoband | 19q13.33 | 9.55e-05 | 106 | 315 | 6 | 19q13.33 | |
| Cytoband | 1p13.3 | 1.16e-04 | 69 | 315 | 5 | 1p13.3 | |
| GeneFamily | EF-hand domain containing|Spectrins | 3.86e-09 | 7 | 207 | 5 | 1113 | |
| GeneFamily | Ankyrin repeat domain containing | ANKLE1 AGAP11 BCOR SOWAHC CLPB ASB6 ANKRD2 NFKB2 TRPV6 ESPN ANK2 FEM1B ANKRD17 TRPV5 | 8.01e-07 | 242 | 207 | 14 | 403 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.68e-05 | 161 | 207 | 10 | 593 | |
| GeneFamily | Intermediate filaments Type IV | 2.88e-05 | 6 | 207 | 3 | 611 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.50e-05 | 18 | 207 | 4 | 91 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 1.10e-04 | 95 | 207 | 7 | 59 | |
| GeneFamily | Myosin heavy chains | 6.08e-04 | 15 | 207 | 3 | 1098 | |
| GeneFamily | Guanylate cyclases, soluble | 7.71e-04 | 4 | 207 | 2 | 820 | |
| GeneFamily | Erb-b2 receptor tyrosine kinases | 7.71e-04 | 4 | 207 | 2 | 1096 | |
| GeneFamily | SKI transcriptional corepressors | 7.71e-04 | 4 | 207 | 2 | 748 | |
| GeneFamily | SH2 domain containing | 1.08e-03 | 101 | 207 | 6 | 741 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.10e-03 | 40 | 207 | 4 | 321 | |
| GeneFamily | Mannosidases alpha class 2 | 1.28e-03 | 5 | 207 | 2 | 1194 | |
| GeneFamily | Ferlin family | 1.90e-03 | 6 | 207 | 2 | 828 | |
| GeneFamily | Actins|Deafness associated genes | 1.92e-03 | 113 | 207 | 6 | 1152 | |
| GeneFamily | Neuroblastoma breakpoint family | 2.21e-03 | 23 | 207 | 3 | 662 | |
| GeneFamily | EMI domain containing | 2.64e-03 | 7 | 207 | 2 | 540 | |
| GeneFamily | Blood group antigens|CD molecules|Proteoglycans | 2.64e-03 | 7 | 207 | 2 | 570 | |
| GeneFamily | EF-hand domain containing|Plakins | 3.49e-03 | 8 | 207 | 2 | 939 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | PODNL1 PDGFRA MYO6 GAS6 NRXN3 AGT DMD ALDH1A3 MOCS1 HSPB2 TNS3 HSPG2 COL6A3 ANK2 VASN LAMB2 RTN4RL1 EMILIN1 TENM4 LMNA EGFR MYH14 KIAA1755 MAPK4 EPHA3 | 4.64e-06 | 767 | 307 | 25 | M39209 |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED | 8.48e-06 | 12 | 307 | 4 | M47983 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | NES PDGFRA LRRC32 OBSCN GASK1B PXDN AGT DMD ALDH1A3 C8G COL6A3 LAMB2 TEK EMILIN1 ARHGAP6 GUCY1A1 CSPG4 KIAA1755 TRIM49B | 9.33e-06 | 505 | 307 | 19 | M39167 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | TTYH1 GRIPAP1 DCAF6 VWA8 WDR33 ANKLE1 GASK1B CPT1C GPSM2 HERC3 DMD SLC25A23 ZNF367 WHRN ANK2 DTNA LAMB2 DPYSL4 ADGRL1 MAGEE2 CWC22 BAZ1A IQCB1 DAAM1 EPHA3 NOS1AP | 6.50e-06 | 688 | 302 | 26 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4 | TTYH1 GRIPAP1 DCAF6 SPTBN2 SRC GASK1B NRXN3 CPT1C GPSM2 HERC3 DMD SLC25A23 PLXNB1 ZNF367 WHRN DTNA LAMB2 DPYSL4 ADGRL1 MAGEE2 CWC22 BAZ1A IQCB1 NINL EPHA3 | 1.69e-05 | 683 | 302 | 25 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | TTYH1 GRIPAP1 DCAF6 VWA8 SRC FJX1 GASK1B CPT1C GPSM2 HERC3 DMD SLC25A23 WHRN CDC42BPA ANK2 VMAC DTNA LAMB2 DPYSL4 ADGRL1 MAGEE2 HDDC3 IQCB1 EPHA3 | 2.64e-05 | 658 | 302 | 24 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K5 |
| ToppCell | facs-Lung-Endomucin-24m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | VWA8 SRC TKTL1 TBC1D32 ASB6 HSPB2 P4HTM GUCY1A1 GUCY1B1 CSPG4 NINL RTN4RL2 | 3.63e-09 | 173 | 311 | 12 | a37f38478473290fe35aea8684befc3bf95b161f |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FBXL2 HSPB2 PLXNB1 RTN4RL1 FAM81A USP2 NKD1 ARVCF GUCY1A1 GUCY1B1 CSPG4 TMC5 | 7.74e-09 | 185 | 311 | 12 | 30df02fbe2828e3c4f3e5c4cda855e74fb31be39 |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FBXL2 HSPB2 PLXNB1 RTN4RL1 FAM81A USP2 NKD1 ARVCF GUCY1A1 GUCY1B1 CSPG4 TMC5 | 8.73e-09 | 187 | 311 | 12 | 8ff9f771d10c372d771c92dfa9006aa81aec4681 |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DCAF6 GCK RHPN1 LRRC26 DHX29 PLXNB1 PCDHGC4 COL6A6 SPTBN4 EGFR DROSHA | 2.18e-08 | 163 | 311 | 11 | 132aece9c79499b4bb3c2bde68d3d7202e1d8772 |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | TTC34 PXDN CPT1C DMD DTNA DPYSL4 EMILIN1 ARHGAP6 CSPG4 KIAA1755 NOS1AP | 5.09e-08 | 177 | 311 | 11 | e65c0568dc5852108e9802273499bc7cf88fafab |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | NES LRRC32 GAS6 FJX1 MEST COL6A3 VASN GUCY1A1 GUCY1B1 CSPG4 EPHA3 | 8.44e-08 | 186 | 311 | 11 | db4d9ac89cc1e55062ba888b3410b773340595dd |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | TTYH1 LRRC32 GAS6 FJX1 MEST ZFP36L1 COL6A3 VASN GUCY1B1 CSPG4 EPHA3 | 8.91e-08 | 187 | 311 | 11 | 6820bfbe552ea5e62cfe699687b051a17d9fda61 |
| ToppCell | 21-Trachea-Endothelial-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | NES PDGFRA LRRC32 DYSF GASK1B PXDN EXOC3L1 HSPG2 TEK EMILIN1 TIE1 | 1.05e-07 | 190 | 311 | 11 | 08437396a98ca9526f69c3a74bbf2929f3c68b8e |
| ToppCell | 21-Trachea-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | NES PDGFRA LRRC32 DYSF GASK1B PXDN EXOC3L1 HSPG2 TEK EMILIN1 TIE1 | 1.05e-07 | 190 | 311 | 11 | bce09634acbc2cfd53666328e8aed8bf8835f845 |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | PDGFRA FJX1 GASK1B MEST ZFP36L1 PIP5KL1 COL6A3 EMILIN1 GUCY1A1 GUCY1B1 EPHA3 | 1.16e-07 | 192 | 311 | 11 | 20ede290e01ad574afd122d72b59dbc52c595fad |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TTYH1 PDGFRA MEST NRXN3 HSPB2 COL6A3 NKD1 ARVCF GUCY1A1 GUCY1B1 EPHA3 | 1.29e-07 | 194 | 311 | 11 | 7942bc83c1bdca687795b91aa232824d603f9b09 |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TTYH1 PDGFRA MEST NRXN3 HSPB2 COL6A3 NKD1 ARVCF GUCY1A1 GUCY1B1 EPHA3 | 1.29e-07 | 194 | 311 | 11 | 415801a3dfacf05f2b603fb424df3d045190a812 |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TTYH1 PDGFRA MEST NRXN3 HSPB2 COL6A3 NKD1 ARVCF GUCY1A1 GUCY1B1 EPHA3 | 1.29e-07 | 194 | 311 | 11 | 256cb33ec90328f2704921fb0fe0fd9812e138b0 |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | ADAMTS19 PDGFRA EMILIN3 MEST COL6A3 ANK2 COL6A6 LAMB2 EGFR CSPG4 KIAA1755 | 1.67e-07 | 199 | 311 | 11 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea |
| ToppCell | medial-mesenchymal|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | PDGFRA GAS6 MEST MOCS1 HSPB2 COL6A3 VASN EMILIN1 GUCY1A1 GUCY1B1 CSPG4 | 1.76e-07 | 200 | 311 | 11 | 4f19e1e40966e27779bf77e8c170ed3ecc24353e |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | PDGFRA OBSCN C2CD4C FASN KCNC2 AGT PPP1R9B ANK2 DTNA FAM81A SPTBN4 | 1.76e-07 | 200 | 311 | 11 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 |
| ToppCell | medial-2-mesenchymal|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | PDGFRA GAS6 MEST MOCS1 HSPB2 COL6A3 VASN EMILIN1 GUCY1A1 GUCY1B1 CSPG4 | 1.76e-07 | 200 | 311 | 11 | a9d8aa5bcf383d98a9e2eaf4b1f8466982d6b088 |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | PDGFRA OBSCN C2CD4C FASN KCNC2 AGT PPP1R9B ANK2 DTNA FAM81A SPTBN4 | 1.76e-07 | 200 | 311 | 11 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.15e-07 | 181 | 311 | 10 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SRC FJX1 HSPB2 PLXNB1 TTYH2 RTN4RL1 TENM4 GUCY1A1 GUCY1B1 CSPG4 | 6.46e-07 | 182 | 311 | 10 | aba4c06d5d7618ac21b2695bca8e7a1346a91090 |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SRC FJX1 HSPB2 PLXNB1 TTYH2 RTN4RL1 TENM4 GUCY1A1 GUCY1B1 CSPG4 | 6.46e-07 | 182 | 311 | 10 | 9edaccf1154cec92ca9a28e9b1f9075cfd422bfd |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ADAMTS19 GAS6 MEST DMD COL6A3 COL6A6 VASN GALNT9 CSPG4 EPHA3 | 7.14e-07 | 184 | 311 | 10 | 102b6f621a5b551e622f97b12d787c080b052a72 |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_Erythro-Mega-Megakaryocyte_early|lymph-node_spleen / Manually curated celltypes from each tissue | SPTB SRC ALOX12 COL6A3 DTNA GAS2L1 ARHGAP6 PLA2G4C GUCY1B1 MYH14 | 7.14e-07 | 184 | 311 | 10 | 10607d7d92edcbb92d992900086b90b307421cc3 |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.51e-07 | 185 | 311 | 10 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | GRIPAP1 PDGFRA BMP7 PXDN DMD COL6A3 ELP3 EMILIN1 TRNT1 GUCY1B1 | 7.51e-07 | 185 | 311 | 10 | 9878392d79734ab5bb977d7f4f5e2e079b9a5353 |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.51e-07 | 185 | 311 | 10 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.28e-07 | 187 | 311 | 10 | 5b7a1edee602e55d3400dc17dbb6b8aaa26defc0 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.28e-07 | 187 | 311 | 10 | daff7ccd3f1924cf2b34d3aca3eccde245aaf371 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | NES SPTB OBSCN MEST MOCS1 COL6A3 TTYH2 ARHGAP6 GUCY1B1 CSPG4 | 8.28e-07 | 187 | 311 | 10 | 62759efb660179402fb574ce5701c89a2e17bcfe |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | NES LRRC32 OBSCN MEST MOCS1 COL6A3 TTYH2 ARHGAP6 GUCY1B1 CSPG4 | 8.28e-07 | 187 | 311 | 10 | a2bf958ea59c359a265bfa437d59315e1920cdd4 |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | BMP7 MYO15B ZFP36L1 MOG PLXNB1 TNS3 DOCK1 TTYH2 TLR4 KIAA1755 | 9.12e-07 | 189 | 311 | 10 | 42ab4cc5fbf8580841f31889446fe4499df1a464 |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | NES LRRC32 OBSCN MEST MOCS1 COL6A3 TTYH2 ARHGAP6 GUCY1B1 CSPG4 | 9.12e-07 | 189 | 311 | 10 | d7ed96add29f219183c802895fbff519b627f635 |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | BMP7 MYO15B ZFP36L1 MOG PLXNB1 TNS3 DOCK1 TTYH2 TLR4 KIAA1755 | 9.12e-07 | 189 | 311 | 10 | 37ecbd73408d462b47d7e5611f203143e08a2689 |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.57e-07 | 190 | 311 | 10 | cb8798839c27f307955fcc94a1ee40bca95b8e99 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.57e-07 | 190 | 311 | 10 | 5bf3d0beee69879c95265d07fba023626a7cc808 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.57e-07 | 190 | 311 | 10 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.57e-07 | 190 | 311 | 10 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | BMP7 MYO15B ZFP36L1 MOG PLXNB1 TNS3 DOCK1 TTYH2 TLR4 KIAA1755 | 1.00e-06 | 191 | 311 | 10 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | BMP7 MYO15B ZFP36L1 MOG PLXNB1 TNS3 DOCK1 TTYH2 TLR4 KIAA1755 | 1.00e-06 | 191 | 311 | 10 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | PDGFRA PXDN AGT DMD ALDH1A3 COL6A3 CDC42BPA DTNA EMILIN1 ARHGAP6 | 1.10e-06 | 193 | 311 | 10 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SPTBN2 NEFH NRXN3 KCNC2 ADGRL1 PPFIA3 SPTBN4 SLC8A2 TENM4 NOS1AP | 1.10e-06 | 193 | 311 | 10 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SPTBN2 NEFH NRXN3 KCNC2 ADGRL1 PPFIA3 SPTBN4 SLC8A2 TENM4 NOS1AP | 1.10e-06 | 193 | 311 | 10 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SPTBN2 NEFH NRXN3 KCNC2 ADGRL1 PPFIA3 SPTBN4 SLC8A2 TENM4 NOS1AP | 1.10e-06 | 193 | 311 | 10 | 0c652ebe22ce5d2927599dd97ef1920547858395 |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | LRRC32 CRACR2B MEST PXDN EXOC3L1 HSPG2 TEK EMILIN1 NKD1 TIE1 | 1.21e-06 | 195 | 311 | 10 | 85df110f753f58ab017018c54ee454edb4428e29 |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | TTYH1 NES LRRC32 FJX1 HSPB2 COL6A3 VASN GUCY1A1 GUCY1B1 CSPG4 | 1.21e-06 | 195 | 311 | 10 | 9b3fa1d42ec5aa2911f27a99cd8b57714c6bd604 |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | GAS6 MEST MOCS1 HSPB2 COL6A3 VASN NKD1 GUCY1A1 GUCY1B1 CSPG4 | 1.27e-06 | 196 | 311 | 10 | 9d18381d7aaa063094a5df769a04c73350471525 |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-06 | 196 | 311 | 10 | acbb493dbb49a33f20cf11106363f7ed51209706 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | GAS6 MEST MOCS1 HSPB2 COL6A3 VASN NKD1 GUCY1A1 GUCY1B1 CSPG4 | 1.27e-06 | 196 | 311 | 10 | afddacc0fb8b9c73dad5333137deb471a6ebdc06 |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Macroglial-Astrocyte|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.27e-06 | 196 | 311 | 10 | 55a10faafcbe075eefdfcd7cff25ded040c23538 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Macroglial|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.27e-06 | 196 | 311 | 10 | 8025ec8aee8455c7b0261aa4a0caacebd2f50634 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | GAS6 MEST MOCS1 HSPB2 COL6A3 VASN NKD1 GUCY1A1 GUCY1B1 CSPG4 | 1.27e-06 | 196 | 311 | 10 | a52cb512c6173be92aa9c4d96e2abbc32f45478d |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | PODNL1 SOWAHC AGT MOCS1 COL6A3 ANK2 COL6A6 ARHGAP6 NKD1 DAAM1 | 1.33e-06 | 197 | 311 | 10 | 4edf043e8f586fd375f56485841fe992a18bf853 |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | PDGFRA GAS6 MEST AGT ALDH1A3 MOCS1 COL6A3 EMILIN1 TENM4 EGFR | 1.33e-06 | 197 | 311 | 10 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | PDGFRA GAS6 MEST AGT ALDH1A3 MOCS1 COL6A3 EMILIN1 TENM4 EGFR | 1.33e-06 | 197 | 311 | 10 | b9745e382baa2725dfcae060701fb53f6c8a31fa |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-06 | 197 | 311 | 10 | 01249bd485a3734de87ae6ed9c749597f39c6335 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | PDGFRA GAS6 MEST AGT ALDH1A3 MOCS1 COL6A3 EMILIN1 TENM4 EGFR | 1.33e-06 | 197 | 311 | 10 | 1baffd087ca194a7355fefbb3bf67befb14fe2de |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ERBB2 NRXN3 PLXNB1 TNS3 HSPG2 DSP SLC26A5 MYH14 LRRC1 SLC4A11 | 1.39e-06 | 198 | 311 | 10 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | PDGFRA FJX1 GASK1B MEST PXDN ZFP36L1 COL6A3 GUCY1A1 GUCY1B1 EPHA3 | 1.39e-06 | 198 | 311 | 10 | 12cd9f0bbad8dce5199ebfed1c4a8080710ca055 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | PODNL1 GASK1B PXDN HSPG2 COL6A3 P4HA2 VASN EMILIN1 LMNA GUCY1A1 | 1.39e-06 | 198 | 311 | 10 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-06 | 199 | 311 | 10 | da5a88749d859d535daa030d0974485906cc0ba7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-06 | 200 | 311 | 10 | ced14d83222dbebca85c40540e76824e683354f3 | |
| ToppCell | proximal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.52e-06 | 200 | 311 | 10 | 98cbd0f4994e645f70c0bc5ebc1c3a3b28c6b67f | |
| ToppCell | distal-2-mesenchymal|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | MEST MOCS1 HSPB2 COL6A3 VASN EMILIN1 NKD1 GUCY1A1 GUCY1B1 CSPG4 | 1.52e-06 | 200 | 311 | 10 | 65a50f03b0027ccefb51b8f77afa283d4a3b3567 |
| ToppCell | proximal-mesenchymal-Pericyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.52e-06 | 200 | 311 | 10 | 03119a979bc912a98e6fc87addcbc25d8ecf2fb0 | |
| ToppCell | proximal-mesenchymal-Pericyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.52e-06 | 200 | 311 | 10 | a81fde3d40b8efb3be535aeb2a44cfbdeb17bc8b | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.78e-06 | 125 | 311 | 8 | 2938a1d62afe1e0a3abba5eb92f07b886cc0accd | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.20e-06 | 170 | 311 | 9 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-06 | 172 | 311 | 9 | ab1c81be29f93ca8920c6ab5ab92f497a9256d3f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-06 | 172 | 311 | 9 | 1ef243bce63d841c25e4b74d029d1377f84bcc3d | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.52e-06 | 172 | 311 | 9 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.87e-06 | 174 | 311 | 9 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-06 | 175 | 311 | 9 | d2ff8fedca9039cbd45cfd9dec88f4edbe7fe4fc | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-06 | 175 | 311 | 9 | a7310950e8d51b3004ea3aee8ce9948fe8655112 | |
| ToppCell | facs-Heart-RA-3m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-06 | 175 | 311 | 9 | 7b38cbd73be26cf33393c6e6c804d62856a91ec3 | |
| ToppCell | facs-Heart-RA-3m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-06 | 175 | 311 | 9 | db977f18a71845ecb16ee3e6b3fb03dea4a1a8bc | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.25e-06 | 176 | 311 | 9 | f931192e3cc65414e2245354f443473696cc7ce8 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.25e-06 | 176 | 311 | 9 | e2b59a904c5c8f9c88e1e63788e9b6485f22edd0 | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | DYSF GASK1B ZFP36L1 UAP1L1 PLXNB1 APOA1 ARHGEF40 NINL PCDHGC3 | 4.45e-06 | 177 | 311 | 9 | 470f54fe2b21c7350ea471e02039461a3808f700 |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-06 | 177 | 311 | 9 | 8684d47a547e2a06496f15e8da0200ecddc431e0 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-06 | 177 | 311 | 9 | 65709bd546cb1ec6aa2ddd8b2adb46e174eb9a9a | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.45e-06 | 177 | 311 | 9 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.65e-06 | 178 | 311 | 9 | 8bae5db100f4563aa1fc7f881e7f8c59d669e37a | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.65e-06 | 178 | 311 | 9 | bc0336692b84bd0fa49747ed5a031b8ed8afa0fd | |
| ToppCell | facs-Heart-RA-3m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-06 | 178 | 311 | 9 | ba6ded4455233635a11afcf6f522c786bd81b5e0 | |
| ToppCell | wk_08-11-Epithelial-PNS-Proliferating_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | TTYH1 GASK1B NRXN3 HSPG2 PCDHGC4 APOA1 KIAA1755 ROPN1B ROPN1 | 4.87e-06 | 179 | 311 | 9 | ab23fee9adab1e63d5b5cd9faba6b9a92beef425 |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.10e-06 | 180 | 311 | 9 | a37cc885fe3f6cb9df69d43358064c83c18412e7 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.10e-06 | 180 | 311 | 9 | 63a6d532b16b8b15c7c9102148d7297ee3afd641 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte|E18.5-samps / Age Group, Lineage, Cell class and subclass | LRRC32 FJX1 HSPB2 COL6A6 TTYH2 RTN4RL1 GUCY1A1 GUCY1B1 CSPG4 | 5.10e-06 | 180 | 311 | 9 | 0b1d370db64862fe1c7ea0ffaf06d03ec82e6e70 |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NHLRC1 PODNL1 ZSWIM2 NRXN3 EXOC3L1 FBXL15 RANGRF CDK5RAP1 ABHD11 | 5.33e-06 | 181 | 311 | 9 | 064057ab36c6d92c36572b73142b42d201709d7b |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.33e-06 | 181 | 311 | 9 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.33e-06 | 181 | 311 | 9 | ab66a89f316b935d9ba1277426d976b1e9e39757 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|normal_Lung / Location, Cell class and cell subclass | 5.33e-06 | 181 | 311 | 9 | f74941e49950027360d71ea3b205fc20c6929766 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.58e-06 | 182 | 311 | 9 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.58e-06 | 182 | 311 | 9 | a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.58e-06 | 182 | 311 | 9 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.58e-06 | 182 | 311 | 9 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | facs-Lung-Endomucin-24m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | VWA8 TKTL1 TBC1D32 HSPB2 RTN4RL1 P4HTM GUCY1A1 GUCY1B1 CSPG4 | 5.58e-06 | 182 | 311 | 9 | be9c312a44868d4ee266a64d066feb8c5bce5687 |
| ToppCell | facs-Lung-Endomucin-24m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | VWA8 TKTL1 TBC1D32 HSPB2 RTN4RL1 P4HTM GUCY1A1 GUCY1B1 CSPG4 | 5.58e-06 | 182 | 311 | 9 | 74dbb706bcaa0f8c922bf3b0424bce5bb27167fa |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | HSPB2 COL6A6 LAMB2 RTN4RL1 EMILIN1 ARHGAP6 GUCY1A1 GUCY1B1 CSPG4 | 5.58e-06 | 182 | 311 | 9 | ffe500d78a89dc6b4d05bab1664e7f30c94fb8d9 |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.58e-06 | 182 | 311 | 9 | 831b5ce46b41efe01c4db6016c2f43148611373d | |
| Drug | ponatinib | 2.43e-08 | 68 | 306 | 10 | ctd:C545373 | |
| Drug | CP-645525-01 [287190-82-3]; Down 200; 10uM; MCF7; HT_HG-U133A | TRIO WDR33 SPTBN2 DYSF TBCD WHRN DTNA DPYSL4 OPA3 KCNK12 ECPAS MTOR LRRC1 TMC5 NOS1AP | 7.71e-08 | 197 | 306 | 15 | 7522_DN |
| Drug | fullerene C60 | MGAT4B DCAF6 TRIO SRC CHAD SRCAP TTC34 TRIM11 ZBTB39 ASB6 FBXW5 FES PPP1R37 EXOC3L1 SCLT1 FBXL2 VARS1 FMNL1 MOCS1 ESPN CARM1 WHRN CDC42BPG LRFN1 ZNF775 VMAC TMED5 TTYH2 POR RTN4RL1 APOA1 VPS25 YES1 MAP3K6 CDC42BPB USP2 ORAI1 TKFC P4HTM TENM4 TIE1 EEPD1 PDE4DIP OXNAD1 TMC5 RTN4RL2 | 1.30e-07 | 1498 | 306 | 46 | ctd:C069837 |
| Drug | SC 19220; Down 200; 10uM; PC3; HT_HG-U133A | EPPK1 VWA8 ZCCHC2 SRCAP BCOR MOCS1 DOCK1 WHRN HSPG2 DPYSL4 ADGRL1 PEX26 KBTBD4 PDE4DIP | 3.57e-07 | 192 | 306 | 14 | 7065_DN |
| Drug | ADPribulose | 5.00e-07 | 13 | 306 | 5 | CID000197570 | |
| Drug | Droperidol [548-73-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | LRFN3 SRC DYSF BMP7 CLCN7 NFKB2 CFAP410 CDC42BPA DTNA CDC42BPB PEX26 ARVCF MYH14 | 2.71e-06 | 196 | 306 | 13 | 2645_DN |
| Drug | Timolol maleate salt [26921-17-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A | RTEL1 SRCAP AGT TAB1 CFAP410 TBCD WHRN CDC42BPA DTNA LMNA ARHGEF2 DHX34 NOS1AP | 2.71e-06 | 196 | 306 | 13 | 5280_DN |
| Drug | radicicol; Up 200; 0.1uM; MCF7; HT_HG-U133A | TRIO RTEL1 SPTAN1 SPTB TKTL1 SRCAP CLCN7 FBXL2 WHRN P4HA2 CDC42BPA PLA2G4C EGFR | 2.71e-06 | 196 | 306 | 13 | 5947_UP |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A | EPPK1 TRIO SPTAN1 LRFN3 ITGB7 CLCN7 CFAP410 CDC42BPA ATN1 RHBG SKI PDE4DIP NOS1AP | 2.71e-06 | 196 | 306 | 13 | 5232_UP |
| Drug | Metrizamide [31112-62-6]; Up 200; 5uM; PC3; HT_HG-U133A | PODNL1 ACOX3 CHRND AGT ALOX12 ANK2 GPT APBA1 HUWE1 USP2 TLR4 MYH15 EPHA3 | 2.71e-06 | 196 | 306 | 13 | 4075_UP |
| Drug | Tetracaone hydrochloride [136-47-0]; Up 200; 13.2uM; MCF7; HT_HG-U133A | TTYH1 ERBB2 TRIO LRFN3 SRCAP SPTBN5 NFKB2 SLC25A23 CDC42BPA FBXL15 LMNA EGFR MYH14 | 2.87e-06 | 197 | 306 | 13 | 2888_UP |
| Drug | Gliquidone [33342-05-1]; Down 200; 7.6uM; PC3; HT_HG-U133A | SRC GAS6 TYK2 FBXL2 WHRN FBXL15 PPFIA3 IGFLR1 TKFC GUCY1B1 PDE4DIP DAAM1 DHX34 | 2.87e-06 | 197 | 306 | 13 | 7301_DN |
| Drug | Theobromine [83-67-0]; Down 200; 22.2uM; MCF7; HT_HG-U133A | RABEP2 SPTAN1 SPTBN2 DYSF DPYSL4 OPA3 KCNK12 SKIL PLA2G4C ARVCF PDE4DIP HYI DHX34 | 2.87e-06 | 197 | 306 | 13 | 3334_DN |
| Drug | Carbarsone [121-59-5]; Down 200; 15.4uM; PC3; HT_HG-U133A | TRIO RTEL1 ITGB7 UAP1L1 WHRN HSPG2 ATN1 DTNA ADGRL1 ECPAS IGFLR1 TENM4 EGFR | 3.39e-06 | 200 | 306 | 13 | 3991_DN |
| Drug | CCRIS 4306 | 7.24e-06 | 21 | 306 | 5 | CID011984829 | |
| Drug | 3-(4-Amino-5-cyclopropylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo(3,4-b)pyridine | 9.52e-06 | 4 | 306 | 3 | ctd:C423582 | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | PODNL1 TRIO SPTBN2 ALOX12 PLXNB1 TBCD HSPG2 ATN1 DTNA ADGRL1 OPA3 GAS2L1 | 1.33e-05 | 194 | 306 | 12 | 4246_DN |
| Drug | Thiocolchicoside [602-41-5]; Up 200; 7uM; MCF7; HT_HG-U133A | RABEP2 SPTB SRCAP ZFP36L1 HERC3 MOCS1 HSPG2 COL6A3 CDC42BPA ATN1 SH2D2A EGFR | 1.40e-05 | 195 | 306 | 12 | 2875_UP |
| Drug | plakin | 1.46e-05 | 82 | 306 | 8 | CID000018752 | |
| Drug | Debrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A | EPPK1 SPTAN1 CLCN7 GTPBP3 SLC25A23 MOCS1 CARM1 FBXL15 SKI CDC42BPB PEX26 MTOR | 1.48e-05 | 196 | 306 | 12 | 5288_UP |
| Drug | DNA-PK Inhibitor III; Down 200; 1uM; MCF7; HT_HG-U133A | PODNL1 RTEL1 SPTAN1 SRC BMP7 ATN1 BLZF1 ELP3 PEX26 TTC23 LMNA EGFR | 1.48e-05 | 196 | 306 | 12 | 7513_DN |
| Drug | GSK-3beta Inhibitor VIII; Up 200; 10uM; MCF7; HT_HG-U133A | LRFN3 SRCAP BMP7 TBCD WHRN HSPG2 HAUS5 LMNA PDE4DIP TMC5 EPHA3 NOS1AP | 1.48e-05 | 196 | 306 | 12 | 7092_UP |
| Drug | PF-00562151-00 [351320-12-2]; Down 200; 10uM; PC3; HT_HG-U133A | VWA8 SPTBN2 GAS6 NRXN3 NFKB2 TRPV6 TBCD ATN1 FEM1B ARHGAP6 CSPG4 DHX34 | 1.48e-05 | 196 | 306 | 12 | 6863_DN |
| Drug | Iodixanol [92339-11-2]; Down 200; 2.6uM; MCF7; HT_HG-U133A | RTEL1 DYSF NFKB2 FBXL2 PLXNB1 DTNA DPYSL4 PEX26 USP2 LMNA EGFR ARVCF | 1.48e-05 | 196 | 306 | 12 | 3362_DN |
| Drug | 15(S)-15-methyl Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A | WDR33 TAB1 TBCD WHRN HSPG2 HAUS5 DPYSL4 OPA3 KCNK12 PPFIA3 MTOR LRRC1 | 1.64e-05 | 198 | 306 | 12 | 7521_DN |
| Drug | Hyoscyamine (L) [101-31-5]; Up 200; 13.8uM; MCF7; HT_HG-U133A | ACTN3 ZFP36L1 NFKB2 TAB1 CFAP410 RHBG ADGRL1 KCNK12 HUWE1 USP2 PLA2G4C EPHA3 | 1.64e-05 | 198 | 306 | 12 | 5524_UP |
| Drug | Azapropazone [13539-59-8]; Up 200; 13.4uM; MCF7; HT_HG-U133A | SRC CHRND NEFH TAB1 WHRN DTNA SH2D2A USP2 TENM4 ARVCF GUCY1B1 DHX34 | 1.64e-05 | 198 | 306 | 12 | 6522_UP |
| Drug | pioglitazone HCl; Up 200; 10uM; MCF7; HT_HG-U133A | SPTAN1 SOWAHC BMP7 CLCN7 CFAP410 TBCD HSPG2 PPFIA3 TENM4 RANGRF PDE4DIP DHX34 | 1.64e-05 | 198 | 306 | 12 | 7083_UP |
| Drug | Ifosfamide [3778-73-2]; Down 200; 15.4uM; MCF7; HT_HG-U133A | EPPK1 WDR33 GASK1B BMP7 SLC25A23 CFAP410 DTNA KCNK12 PPFIA3 LMNA PDE4DIP DHX34 | 1.72e-05 | 199 | 306 | 12 | 3485_DN |
| Drug | Testosterone propionate [57-85-2]; Up 200; 11.6uM; HL60; HT_HG-U133A | VWA8 RTEL1 FJX1 NEFH ZBTB39 NFKB2 ALOX12 HSPG2 CDC42BPA DTNA OPA3 DHX34 | 1.72e-05 | 199 | 306 | 12 | 1295_UP |
| Drug | Riboflavine [83-88-5]; Up 200; 10.6uM; PC3; HT_HG-U133A | VWA8 SPTAN1 ACTN3 BMP7 DMD ATN1 GPT DPYSL4 HUWE1 RET ARSD MYH14 | 1.72e-05 | 199 | 306 | 12 | 4485_UP |
| Drug | Scopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | RTEL1 LRFN3 SRCAP FBXL2 CFAP410 DTNA HAUS5 ADGRL1 KCNK12 SKIL PEX26 LMNA | 1.72e-05 | 199 | 306 | 12 | 4803_DN |
| Drug | imatinib | ERBB2 PDGFRA SRC TYK2 FES RET TEK YES1 CDC42BPB CRK TIE1 EGFR MTOR PDE4DIP ROCK1 MAPK1 ARHGEF2 EPHA3 | 2.36e-05 | 430 | 306 | 18 | CID000005291 |
| Drug | dimyristoylphosphatidylcholine | 2.38e-05 | 64 | 306 | 7 | CID000026197 | |
| Drug | AC1L1KMJ | MYO6 SPTAN1 SPTB SPTBN2 SRC SPTBN5 PKD1 ESPN COL6A3 ANK2 MYH7B LAMB2 CRK SPTBN4 GAS2L1 MTOR ROCK1 MAPK1 MAPK4 | 2.70e-05 | 476 | 306 | 19 | CID000030956 |
| Drug | Zardaverine [101975-10-4]; Up 200; 15uM; HL60; HT_HG-U133A | RTEL1 SPTAN1 TKTL1 CLCN7 SH2D2A SKIL BLZF1 ARSD LMNA TMC5 TRPV5 | 2.77e-05 | 176 | 306 | 11 | 2926_UP |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | EPPK1 PDGFRA SPTAN1 UAP1L1 TBCD WHRN DPYSL4 USP2 GUCY1B1 PDE4DIP DAAM1 | 2.92e-05 | 177 | 306 | 11 | 7387_UP |
| Drug | PRODAN | 3.89e-05 | 15 | 306 | 4 | CID000028127 | |
| Drug | wartmannin | ERBB2 PDGFRA MYO6 SRC GAS6 TYK2 PIK3R4 FASN ZFP36L1 NFKB2 AGT TRPV6 HSPB2 MYH7B IFI44 RET TEK YES1 CRK EGFR MYH14 MTOR BLOC1S3 ROCK1 MAPK1 MAPK4 | 4.20e-05 | 811 | 306 | 26 | CID000005691 |
| Drug | PKI166 | 4.28e-05 | 48 | 306 | 6 | CID006918403 | |
| Drug | Forskolin, from Coleus forskohlii; Up 200; 0.5uM; MCF7; HT_HG-U133A | NES ZBTB39 PLXNB1 WHRN HSPG2 POR PEX26 UTP25 PDE4DIP ARHGEF2 NOS1AP | 4.38e-05 | 185 | 306 | 11 | 7055_UP |
| Drug | dimethyl adipimidate | 4.59e-05 | 30 | 306 | 5 | CID000025738 | |
| Drug | tetrathionate | 4.83e-05 | 49 | 306 | 6 | CID000026259 | |
| Drug | AC1L1FF5 | 5.46e-05 | 157 | 306 | 10 | CID000003209 | |
| Drug | vandetanib | 5.77e-05 | 99 | 306 | 8 | CID003081361 | |
| Drug | 2,5-hexanedione | 5.77e-05 | 99 | 306 | 8 | ctd:C011269 | |
| Drug | S-(-)-Etomoxir | 6.20e-05 | 100 | 306 | 8 | CID000060765 | |
| Drug | Taurine | 6.37e-05 | 129 | 306 | 9 | ctd:D013654 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | SRC DYSF FES TRPV6 TAB1 FMNL1 CDC42BPA SKI MYH14 CSPG4 DHX34 | 6.43e-05 | 193 | 306 | 11 | 3077_DN |
| Drug | 4-(3,5-dimethoxystyryl)phenyl acetate | 6.63e-05 | 17 | 306 | 4 | ctd:C000602001 | |
| Drug | Equilin [474-86-2]; Down 200; 15uM; MCF7; HT_HG-U133A | RABEP2 EPPK1 TRIO CDC42BPA ATN1 KCNK12 SKIL FEM1B EGFR DHX34 NOS1AP | 6.73e-05 | 194 | 306 | 11 | 3377_DN |
| Drug | Fusaric acid [536-69-6]; Up 200; 22.4uM; MCF7; HT_HG-U133A | PPP1R37 FBXL2 MOCS1 DOCK1 WHRN CDC42BPA ADGRL1 KCNK12 ARVCF MYH14 TMC5 | 6.73e-05 | 194 | 306 | 11 | 3245_UP |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | CLCN7 TRPV6 TAB1 UAP1L1 MOCS1 DOCK1 HSPG2 ATN1 DTNA ADGRL1 PEX26 | 6.73e-05 | 194 | 306 | 11 | 4001_DN |
| Drug | Heliotrine [303-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A | SPTBN2 ZFP36L1 NFKB2 FBXL2 CFAP410 HSPG2 ECPAS BLZF1 LMNA ARVCF ARHGEF2 | 7.05e-05 | 195 | 306 | 11 | 6035_DN |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 7.05e-05 | 195 | 306 | 11 | 3523_DN | |
| Drug | cox-2 inhibitor I; Up 200; 10uM; MCF7; HG-U133A | SRC CLCN7 ASB6 PLXNB1 TCF7 CDC42BPA DTNA KBTBD4 UTP25 ARVCF DHX34 | 7.05e-05 | 195 | 306 | 11 | 207_UP |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | EPPK1 SPTBN2 SRCAP CLCN7 ANKRD2 PLXNB1 TBCD HSPG2 ATN1 ARVCF DHX34 | 7.05e-05 | 195 | 306 | 11 | 3941_DN |
| Drug | Fluorometholone [426-13-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A | TRIO WDR33 PIWIL1 SRCAP PLXNB1 APBA1 PLA2G4C ARSD TLR4 DDX3Y NOS1AP | 7.05e-05 | 195 | 306 | 11 | 6071_UP |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | TRIO SRCAP ZFP36L1 SLC25A23 DOCK1 ATN1 DTNA SKIL PLA2G4C ARVCF PCDHGC3 | 7.05e-05 | 195 | 306 | 11 | 3923_DN |
| Drug | Seneciphylline [480-81-9]; Down 200; 12uM; PC3; HT_HG-U133A | PODNL1 TRIO ZFP36L1 TRPV6 TAB1 ALOX12 PLXNB1 WHRN ATN1 PEX26 GAS2L1 | 7.38e-05 | 196 | 306 | 11 | 4238_DN |
| Drug | Amphotericin B [1397-89-3]; Down 200; 4.4uM; MCF7; HT_HG-U133A | SRC ZFP36L1 HERC3 TAB1 HAUS5 ECPAS BLZF1 MAP3K6 LMNA ARVCF ARHGEF2 | 7.38e-05 | 196 | 306 | 11 | 5404_DN |
| Drug | Thapsigargin | NES PDGFRA SPTAN1 FJX1 BID NEFH NCAPG GANAB SARS1 CPT1C NFKB2 AGT PKD1 GPSM2 ALDH1A3 SCLT1 TIMM44 VARS1 TNS3 COL6A3 DTNA DPYSL4 RET CRK POLR3A YARS2 ORAI1 ZZZ3 EGFR BAZ1A EEPD1 PDE4DIP ANKRD17 MAPK1 ARHGEF2 CCDC171 | 7.40e-05 | 1353 | 306 | 36 | ctd:D019284 |
| Drug | aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A | RTEL1 FBXL2 UAP1L1 ALOX12 RHBG ADGRL1 OPA3 ECPAS PEX26 ARVCF MYH15 | 7.73e-05 | 197 | 306 | 11 | 6964_UP |
| Drug | PNU-0251126 [267429-19-6]; Down 200; 1uM; MCF7; HT_HG-U133A | TRIO SPTAN1 CLCN7 ATN1 DTNA SKI PEX26 PDE4DIP ARHGEF2 DHX34 EPHA3 | 7.73e-05 | 197 | 306 | 11 | 4714_DN |
| Drug | Ampicillin trihydrate [7177-48-2]; Down 200; 10uM; HL60; HG-U133A | PODNL1 SPTAN1 ACOX3 NEFH FUBP3 MAN2B2 FBXL15 IGFLR1 LMNA ROCK1 HYI | 7.73e-05 | 197 | 306 | 11 | 2030_DN |
| Drug | Cefotetan [69712-56-7]; Up 200; 7uM; MCF7; HT_HG-U133A | PODNL1 TRIO SRCAP GASK1B WHRN HSPG2 GPT HUWE1 USP2 EGFR ARHGEF2 | 7.73e-05 | 197 | 306 | 11 | 4116_UP |
| Drug | Cyclizine hydrochloride [303-25-3]; Up 200; 13.2uM; MCF7; HT_HG-U133A | TTYH1 ERBB2 SPTB NFKB2 SLC25A23 MOCS1 ATN1 RHBG FBXL15 BLZF1 ARVCF | 7.73e-05 | 197 | 306 | 11 | 2880_UP |
| Drug | Adamantamine fumarate [80789-67-9]; Up 200; 9.6uM; PC3; HT_HG-U133A | TRIO CHAD SRCAP CHRND NRXN3 TRPV6 ATN1 DTNA KCNK12 ARSD TIE1 | 7.73e-05 | 197 | 306 | 11 | 4222_UP |
| Drug | Sulfaguanidine [57-67-0]; Down 200; 18.6uM; MCF7; HT_HG-U133A | RABEP2 EPPK1 LRIG2 CLCN7 NFKB2 PPFIA3 PEX26 LMNA ARVCF PDE4DIP PALS2 | 7.73e-05 | 197 | 306 | 11 | 1495_DN |
| Drug | Benperidol [2062-84-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A | SRCAP CLCN7 ZFP36L1 HERC3 SKI BLZF1 PEX26 PLA2G4C ARVCF ASCL2 ARHGEF2 | 7.73e-05 | 197 | 306 | 11 | 2836_UP |
| Drug | 16-phenyl tetranor Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A | VWA8 SRC CFAP410 CDC42BPA ATN1 DTNA PEX26 FEM1B LMNA EGFR LRRC1 | 8.09e-05 | 198 | 306 | 11 | 7505_DN |
| Drug | Melatonin [73-31-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A | RTEL1 SPTAN1 SRC SPTBN5 TRPV6 MOCS1 CFAP410 PLXNB1 ADGRL1 ECPAS PDE4DIP | 8.09e-05 | 198 | 306 | 11 | 5393_DN |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; HL60; HT_HG-U133A | GAS6 ACOX3 TAB1 TBCD CDC42BPA HAUS5 IFI44 TTC23 MYH14 LRRC1 DHX34 | 8.09e-05 | 198 | 306 | 11 | 2146_DN |
| Drug | Levonordefrin [829-74-3]; Up 200; 21.8uM; MCF7; HT_HG-U133A | TRIO SPTAN1 SRCAP ALOX12 MOCS1 RHBG PPFIA3 USP2 LMNA MYH14 DHX34 | 8.09e-05 | 198 | 306 | 11 | 3450_UP |
| Drug | Isocorydine (+) [475-67-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | VWA8 GAS6 CLCN7 ZFP36L1 CDC42BPA DTNA PPFIA3 PEX26 LMNA HYI DHX34 | 8.09e-05 | 198 | 306 | 11 | 6843_DN |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | NES EPPK1 SPTAN1 ZBTB39 PLXNB1 HAUS5 ADGRL1 BLZF1 EGFR PDE4DIP DHX34 | 8.09e-05 | 198 | 306 | 11 | 5335_DN |
| Drug | LY294002 | ERBB2 PDGFRA MYO6 SRC GAS6 TYK2 PIK3R4 FASN NFKB2 AGT FES HSPB2 MYH7B IFI44 RET TEK YES1 CRK EGFR MYH14 MTOR ROCK1 MAPK1 MAPK4 | 8.22e-05 | 748 | 306 | 24 | CID000003973 |
| Drug | pyrophosphate | ERVK-6 MYO6 ACOX3 SARS1 AARS2 ANAPC7 UAP1L1 VARS1 MOCS1 ANAPC4 NSF MYH7B POR POLR3A YARS2 TRNT1 TKFC GTF2H4 GUCY1A1 GUCY1B1 MYH14 FLAD1 | 8.30e-05 | 654 | 306 | 22 | CID000001023 |
| Drug | Natamycin [7681-93-8]; Down 200; 6uM; MCF7; HT_HG-U133A | RABEP2 NES EPPK1 NFKB2 DTNA OPA3 PPFIA3 ARVCF HYI DHX34 EPHA3 | 8.46e-05 | 199 | 306 | 11 | 3548_DN |
| Drug | Sulfasalazine [599-79-1]; Up 200; 10uM; MCF7; HT_HG-U133A | RABEP2 SRCAP SLC25A23 CFAP410 DTNA FBXL15 HUWE1 PLA2G4C EGFR MYH14 DHX34 | 8.46e-05 | 199 | 306 | 11 | 2882_UP |
| Drug | Ioxaglic acid [59017-64-0]; Up 200; 3.2uM; HL60; HT_HG-U133A | RABEP2 NES RTEL1 NFKB2 FBXL2 TBCD HSPG2 CDC42BPA SH2D2A RET CSPG4 | 8.46e-05 | 199 | 306 | 11 | 2966_UP |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Down 200; 10.4uM; PC3; HT_HG-U133A | RABEP2 VWA8 BID CLPB CDC42BPA ATN1 ADGRL1 PPFIA3 IGFLR1 PEX26 ARHGEF2 | 8.46e-05 | 199 | 306 | 11 | 7295_DN |
| Drug | Gabexate mesilate [56974-61-9]; Up 200; 9.6uM; PC3; HT_HG-U133A | CHRND FNDC11 NFKB2 PPP1R37 ALOX12 TEK EMILIN1 USP2 DDX3Y EPHA3 NOS1AP | 8.46e-05 | 199 | 306 | 11 | 4220_UP |
| Drug | Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; PC3; HT_HG-U133A | TRIO RTEL1 DYSF ZFP36L1 UAP1L1 ADGRL1 SH2D2A PPFIA3 BLZF1 LMNA MYH14 | 8.46e-05 | 199 | 306 | 11 | 7384_UP |
| Drug | Minocycline hydrochloride [13614-98-7]; Down 200; 8uM; MCF7; HT_HG-U133A | RABEP2 TRIO GAS6 SRCAP SLC25A23 PLXNB1 ADGRL1 OPA3 PPFIA3 MTOR IPO13 | 8.46e-05 | 199 | 306 | 11 | 7436_DN |
| Drug | Tetracaone hydrochloride [136-47-0]; Down 200; 13.2uM; MCF7; HT_HG-U133A | LRFN3 SRC NFKB2 SLC25A23 DOCK1 LAMB2 ADGRL1 PPFIA3 PEX26 FEM1B MTOR | 8.46e-05 | 199 | 306 | 11 | 7473_DN |
| Drug | Epiandrosterone [481-29-8]; Up 200; 13.8uM; MCF7; HT_HG-U133A | PODNL1 TRIO NFKB2 ALOX12 CFAP410 WHRN CDC42BPA RHBG KCNK12 MYH15 NOS1AP | 8.46e-05 | 199 | 306 | 11 | 3306_UP |
| Drug | AC1L1G9T | ERBB2 PDGFRA SRC GAS6 TYK2 NFKB2 AGT ALOX12 IFI44 LAMB2 YES1 CRK EGFR MTOR ROCK1 MAPK1 MAPK4 | 8.73e-05 | 433 | 306 | 17 | CID000003591 |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A | SRC GAS6 BCOR ZBTB39 NFKB2 FBXL2 SLC25A23 DTNA POR ADGRL1 HYI | 8.85e-05 | 200 | 306 | 11 | 2838_DN |
| Drug | Alprenolol hydrochloride [13707-88-5]; Down 200; 14uM; MCF7; HT_HG-U133A | TRIO SRCAP ZBTB39 TBCD DTNA DPYSL4 BLZF1 GAS2L1 ARVCF BAZ1A TMC5 | 8.85e-05 | 200 | 306 | 11 | 6789_DN |
| Drug | Cytisine (-) [485-35-8]; Down 200; 21uM; MCF7; HT_HG-U133A | TRIO SPTAN1 SRC BMP7 CLCN7 SLC25A23 HSPG2 CDC42BPA DTNA HYI DHX34 | 8.85e-05 | 200 | 306 | 11 | 2759_DN |
| Drug | leucine | 9.16e-05 | 167 | 306 | 10 | CID000000857 | |
| Drug | Dieldrin | MAN2B1 PDGFRA PSMA4 SRC DYSF ITGB7 ACOX3 BID MEN1 NEFH LDHD ASB6 AGT FES ANAPC7 ESPN TCF7 RHBG GPT APOA1 RET ELP3 MAP3K6 CRK FEM1B PELP1 EGFR MTOR LRRC1 OXNAD1 MAPK1 PALS2 EPHA3 | 1.06e-04 | 1217 | 306 | 33 | ctd:D004026 |
| Drug | genistein | ERBB2 PDGFRA SRC ITGB7 TYK2 PIK3R4 MEST CLCN7 ZFP36L1 NFKB2 AGT PKD1 TRPV6 ALDH1A3 ALOX12 HSPG2 COL6A3 ATN1 IFI44 LAMB2 APOA1 KCNK13 RET YES1 CRK ORAI1 EGFR MTOR ROCK1 MAPK1 MAPK4 | 1.14e-04 | 1117 | 306 | 31 | CID005280961 |
| Drug | cholesterol alpha-oxide | 1.28e-04 | 8 | 306 | 3 | ctd:C002415 | |
| Drug | O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate | 1.42e-04 | 211 | 306 | 11 | ctd:C009618 | |
| Drug | AC1NS44W | 1.53e-04 | 60 | 306 | 6 | CID005353385 | |
| Drug | NSC 523214 | 1.73e-04 | 147 | 306 | 9 | CID000004752 | |
| Drug | 1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one | NES MAN2B1 NRXN3 KCNC2 NFKB2 UAP1L1 TNS3 DOCK1 HSPG2 MAN2B2 VASN TTYH2 LAMB2 EGFR GALNT9 | 1.74e-04 | 373 | 306 | 15 | ctd:C540355 |
| Drug | N-(2-(4-((3-chloro-4-(3-(trifluoromethyl)phenoxy)phenyl)amino)-5H-pyrrolo(3,2-d)pyrimidin-5-yl)ethyl)-3-hydroxy-3-methylbutanamide | 1.80e-04 | 2 | 306 | 2 | ctd:C570404 | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 4.05e-06 | 4 | 298 | 3 | DOID:0050882 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | PDGFRA GCK ZCCHC2 SRCAP DYSF PIK3R4 FASN ARID1B PXDNL PKD1 FES TNS3 DIP2B COL6A3 P4HA2 ANK2 VASN VPS25 YES1 CWC22 CRK SPTBN4 B9D2 TENM4 ARVCF GUCY1A1 EEPD1 GALNT9 LRRC1 KIAA1755 MAPK4 TRIM49B DHX34 | 5.38e-06 | 1392 | 298 | 33 | EFO_0005763 |
| Disease | carcinoma (implicated_via_orthology) | 4.63e-05 | 64 | 298 | 6 | DOID:305 (implicated_via_orthology) | |
| Disease | cancer (implicated_via_orthology) | SRC ITGB7 ARID1B GPSM2 VPS25 RET YES1 MTOR FLAD1 LRRC1 MAPK1 | 9.77e-05 | 268 | 298 | 11 | DOID:162 (implicated_via_orthology) |
| Disease | Nonsyndromic genetic hearing loss | 1.22e-04 | 76 | 298 | 6 | cv:C5680182 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 1.58e-04 | 11 | 298 | 3 | DOID:0060669 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.62e-04 | 80 | 298 | 6 | DOID:12930 (implicated_via_orthology) | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 1.63e-04 | 51 | 298 | 5 | cv:CN043650 | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 1.98e-04 | 29 | 298 | 4 | DOID:11984 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 2.10e-04 | 12 | 298 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | intestinal cancer (implicated_via_orthology) | 2.93e-04 | 32 | 298 | 4 | DOID:10155 (implicated_via_orthology) | |
| Disease | Large cell carcinoma of lung | 2.93e-04 | 32 | 298 | 4 | C0345958 | |
| Disease | Multiple Endocrine Neoplasia | 3.03e-04 | 3 | 298 | 2 | C0027662 | |
| Disease | Autosomal dominant polycystic kidney disease | 3.03e-04 | 3 | 298 | 2 | cv:C0085413 | |
| Disease | sensorineural hearing loss (is_implicated_in) | 3.31e-04 | 33 | 298 | 4 | DOID:10003 (is_implicated_in) | |
| Disease | Malignant Neoplasms | 3.33e-04 | 128 | 298 | 7 | C0006826 | |
| Disease | Left ventricular noncompaction | 3.42e-04 | 14 | 298 | 3 | C1960469 | |
| Disease | Neurodevelopmental Disorders | 3.68e-04 | 93 | 298 | 6 | C1535926 | |
| Disease | ovarian neoplasm | 4.40e-04 | 134 | 298 | 7 | C0919267 | |
| Disease | Malignant neoplasm of ovary | 5.02e-04 | 137 | 298 | 7 | C1140680 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 5.18e-04 | 16 | 298 | 3 | DOID:0110861 (implicated_via_orthology) | |
| Disease | autosomal dominant polycystic kidney disease (is_implicated_in) | 6.02e-04 | 4 | 298 | 2 | DOID:898 (is_implicated_in) | |
| Disease | Sclerocystic Ovaries | 6.76e-04 | 144 | 298 | 7 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 6.76e-04 | 144 | 298 | 7 | C0032460 | |
| Disease | pancreatic cancer (is_implicated_in) | 9.86e-04 | 112 | 298 | 6 | DOID:1793 (is_implicated_in) | |
| Disease | hyperparathyroidism (is_implicated_in) | 9.96e-04 | 5 | 298 | 2 | DOID:13543 (is_implicated_in) | |
| Disease | response to bevacizumab, Proteinuria | 9.96e-04 | 5 | 298 | 2 | EFO_0005943, HP_0000093 | |
| Disease | sick sinus syndrome (is_implicated_in) | 9.96e-04 | 5 | 298 | 2 | DOID:13884 (is_implicated_in) | |
| Disease | Cetuximab response | 9.96e-04 | 5 | 298 | 2 | cv:CN077967 | |
| Disease | acute kidney tubular necrosis (biomarker_via_orthology) | 9.96e-04 | 5 | 298 | 2 | DOID:12556 (biomarker_via_orthology) | |
| Disease | Panitumumab response | 9.96e-04 | 5 | 298 | 2 | cv:CN077999 | |
| Disease | muscular dystrophy (implicated_via_orthology) | 1.19e-03 | 21 | 298 | 3 | DOID:9884 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | 1.23e-03 | 206 | 298 | 8 | C0152013 | |
| Disease | prostate cancer (is_implicated_in) | 1.24e-03 | 117 | 298 | 6 | DOID:10283 (is_implicated_in) | |
| Disease | Nonsyndromic Deafness | 1.39e-03 | 81 | 298 | 5 | C3711374 | |
| Disease | Cardiomyopathy, Dilated | 1.40e-03 | 48 | 298 | 4 | C0007193 | |
| Disease | aortic valve disease (implicated_via_orthology) | 1.48e-03 | 6 | 298 | 2 | DOID:62 (implicated_via_orthology) | |
| Disease | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | 1.48e-03 | 6 | 298 | 2 | C3888239 | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 1.48e-03 | 6 | 298 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | multiple sclerosis (is_marker_for) | 1.51e-03 | 49 | 298 | 4 | DOID:2377 (is_marker_for) | |
| Disease | Alveolitis, Fibrosing | 1.55e-03 | 83 | 298 | 5 | C4721507 | |
| Disease | response to clopidogrel, cardiovascular event measurement | 1.55e-03 | 23 | 298 | 3 | EFO_0006919, GO_1903493 | |
| Disease | Carcinoma of lung | 1.55e-03 | 23 | 298 | 3 | C0684249 | |
| Disease | sciatic neuropathy (implicated_via_orthology) | 1.55e-03 | 23 | 298 | 3 | DOID:11446 (implicated_via_orthology) | |
| Disease | Antihypertensive use measurement | 1.59e-03 | 265 | 298 | 9 | EFO_0009927 | |
| Disease | Cardiomyopathy, Familial Idiopathic | 1.63e-03 | 50 | 298 | 4 | C1449563 | |
| Disease | Pulmonary Fibrosis | 1.72e-03 | 85 | 298 | 5 | C0034069 | |
| Disease | Behcet Syndrome | 1.76e-03 | 24 | 298 | 3 | C0004943 | |
| Disease | renal cell carcinoma (is_marker_for) | 1.96e-03 | 128 | 298 | 6 | DOID:4450 (is_marker_for) | |
| Disease | Aortic Aneurysm | 2.06e-03 | 7 | 298 | 2 | C0003486 | |
| Disease | Polycystic kidney disease, type 2 | 2.06e-03 | 7 | 298 | 2 | C2751306 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 2.06e-03 | 7 | 298 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | SPTBN2 SRC OBSCN NCAPG JAKMIP1 DMD TTLL10 FBXL2 ANAPC4 ANK2 RET ZZZ3 EGFR TLR4 B4GALNT2 EPHA3 | 2.26e-03 | 702 | 298 | 16 | C0009402 |
| Disease | Global developmental delay | 2.37e-03 | 133 | 298 | 6 | C0557874 | |
| Disease | azoospermia (implicated_via_orthology) | 2.49e-03 | 27 | 298 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | retinal vasculature measurement | TRIO DYSF PXDN TTLL10 DNAH5 MOCS1 ZNF367 HSPG2 CDC42BPA TTYH2 USP2 UTP25 NOS1AP | 2.49e-03 | 517 | 298 | 13 | EFO_0010554 |
| Disease | brain connectivity measurement | 2.68e-03 | 400 | 298 | 11 | EFO_0005210 | |
| Disease | 3-Methylglutaconic aciduria | 2.73e-03 | 8 | 298 | 2 | cv:C3696376 | |
| Disease | Henoch-Schoenlein purpura (is_implicated_in) | 2.73e-03 | 8 | 298 | 2 | DOID:11123 (is_implicated_in) | |
| Disease | Embryonal Rhabdomyosarcoma | 2.73e-03 | 8 | 298 | 2 | C0206656 | |
| Disease | Sudden Cardiac Arrest | 2.73e-03 | 8 | 298 | 2 | C1720824 | |
| Disease | age at onset, glioblastoma multiforme | 2.73e-03 | 8 | 298 | 2 | EFO_0000519, EFO_0004847 | |
| Disease | chemotherapy-induced alopecia, methylcobalamin deficiency type cblE | 2.73e-03 | 8 | 298 | 2 | EFO_0005400, MONDO_0009354 | |
| Disease | cerebrovascular disease (is_implicated_in) | 2.73e-03 | 8 | 298 | 2 | DOID:6713 (is_implicated_in) | |
| Disease | kidney disease (is_marker_for) | 2.73e-03 | 8 | 298 | 2 | DOID:557 (is_marker_for) | |
| Disease | Polycystic Kidney, Type 1 Autosomal Dominant Disease | 2.73e-03 | 8 | 298 | 2 | C0887850 | |
| Disease | Sudden Cardiac Death | 2.73e-03 | 8 | 298 | 2 | C0085298 | |
| Disease | sulfatase-modifying factor 1 measurement | 2.73e-03 | 8 | 298 | 2 | EFO_0802098 | |
| Disease | Adenocarcinoma of large intestine | 2.94e-03 | 96 | 298 | 5 | C1319315 | |
| Disease | Bilateral Wilms Tumor | 3.07e-03 | 29 | 298 | 3 | C2930471 | |
| Disease | Malignant neoplasm of breast | ADAMTS19 ERBB2 SPTAN1 SRC OBSCN DYSF CHRND PIK3R4 FASN ARID1B EXOC3L1 DMD PLXNB1 ANK2 SYT3 TEK ELP3 MAP3K6 INA EGFR MTOR | 3.19e-03 | 1074 | 298 | 21 | C0006142 |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 3.35e-03 | 99 | 298 | 5 | DOID:11446 (biomarker_via_orthology) | |
| Disease | intellectual disability (is_implicated_in) | 3.38e-03 | 30 | 298 | 3 | DOID:1059 (is_implicated_in) | |
| Disease | Todd Paralysis | 3.49e-03 | 9 | 298 | 2 | C0234544 | |
| Disease | Paralysed | 3.49e-03 | 9 | 298 | 2 | C0522224 | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 3.49e-03 | 9 | 298 | 2 | C0085548 | |
| Disease | glioblastoma multiforme | 3.49e-03 | 9 | 298 | 2 | EFO_0000519 | |
| Disease | underweight body mass index status | 3.49e-03 | 9 | 298 | 2 | EFO_0005936 | |
| Disease | familial Mediterranean fever (is_implicated_in) | 3.49e-03 | 9 | 298 | 2 | DOID:2987 (is_implicated_in) | |
| Disease | Polycystic Kidney, Autosomal Dominant | 3.49e-03 | 9 | 298 | 2 | C0085413 | |
| Disease | Hirschsprung Disease | 3.72e-03 | 31 | 298 | 3 | C0019569 | |
| Disease | Hereditary hearing loss and deafness | 3.76e-03 | 146 | 298 | 6 | cv:C0236038 | |
| Disease | brain ischemia (biomarker_via_orthology) | 3.81e-03 | 102 | 298 | 5 | DOID:2316 (biomarker_via_orthology) | |
| Disease | Squamous cell carcinoma of lung | 4.07e-03 | 32 | 298 | 3 | C0149782 | |
| Disease | hair colour measurement | SRC BMP7 PXDN ZFP36L1 FES ACSF3 CREB3L3 TBCD CDC42BPA MYH7B TENM4 NINL PALS2 CCDC171 | 4.20e-03 | 615 | 298 | 14 | EFO_0007822 |
| Disease | Muscle Weakness | 4.34e-03 | 10 | 298 | 2 | C0151786 | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 4.34e-03 | 10 | 298 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 4.34e-03 | 10 | 298 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 4.34e-03 | 10 | 298 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 4.34e-03 | 10 | 298 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | temporomandibular joint disorder | 4.34e-03 | 10 | 298 | 2 | EFO_0005279 | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 4.34e-03 | 10 | 298 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 4.34e-03 | 10 | 298 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 4.34e-03 | 10 | 298 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 4.34e-03 | 10 | 298 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | Head and Neck Carcinoma | 4.34e-03 | 10 | 298 | 2 | C3887461 | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 4.34e-03 | 10 | 298 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | Head and Neck Neoplasms | 4.45e-03 | 33 | 298 | 3 | C0018671 | |
| Disease | waist circumference | TRIO TBC1D32 FASN NRXN3 PXDNL TAB1 FBXO33 DMD DNAH5 SYT3 CWC22 | 4.53e-03 | 429 | 298 | 11 | EFO_0004342 |
| Disease | Colonic Neoplasms | 4.58e-03 | 152 | 298 | 6 | C0009375 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALANIHSQLLGLERE | 321 | Q9H313 | |
| LDVAELHRALGQARD | 216 | P24298 | |
| GLRGDLSREQHLAAL | 686 | Q86VI1 | |
| LLDHVRENRGRLGSQ | 806 | P04626 | |
| GLNEEERLIRHLFQE | 21 | Q07001 | |
| GGSLDLVDFVRQHRI | 241 | Q6DHV7 | |
| QLAEEGVRLTQHLAA | 71 | P51689 | |
| SRLQALRGEEVQEHA | 241 | O43822 | |
| RFLLQARDARGAVHV | 111 | P07360 | |
| RRHLQGREDNLTLDI | 576 | O71037 | |
| RRHLQGREDNLTLDI | 576 | Q902F8 | |
| LGQHLLRATADEDLR | 451 | Q8TF27 | |
| LEQVESGLHRALRLQ | 861 | Q8TER5 | |
| ALANTAGEVLLHRLA | 36 | Q9UJX5 | |
| LHRALLVFLAEGERQ | 591 | Q8NAG6 | |
| LVDALLHALQSAVGR | 546 | O00192 | |
| LLDVVNRKARFIHDG | 496 | Q6UVK1 | |
| GRLLRDENLHVLNED | 181 | Q13939 | |
| LDLLFDRQDGILRHV | 26 | Q68CJ9 | |
| ARQAELGREIHALAS | 391 | O15254 | |
| LRDFIIDGLSVERNH | 856 | Q96NH3 | |
| RLQRVAHSEFFIDGL | 491 | Q8NHY0 | |
| RQHLLTNLVEVDGRF | 216 | Q8NFV4 | |
| AHREIYQGRINELLL | 846 | O94910 | |
| ALEAELAALRQRHAE | 121 | Q16352 | |
| RNFVIHRLGDLLISQ | 311 | Q92974 | |
| ILGFTQRLHAAEVER | 976 | Q6TFL3 | |
| VRALQVALGAHLRDA | 226 | Q969Y2 | |
| LAAERQHAERVAALG | 1021 | P54259 | |
| EVAFIHIQRELRLRG | 896 | C9J069 | |
| RGRLLHQLADLVERD | 96 | P47895 | |
| HLLRSEGVELNDRAI | 666 | Q8IYW2 | |
| LAFGDRIALVDQHGR | 51 | Q4G176 | |
| NRSEFLLHEGRLLDI | 2281 | Q8NFD5 | |
| LLHVIARDFDALNER | 186 | Q3SXY8 | |
| LRAELQEGARQKLHE | 146 | P02647 | |
| LTRAADVLLRHGANL | 81 | Q9NWX5 | |
| LASLNHIRADRLEGD | 831 | Q58WW2 | |
| HIENLFSDLQDGRRL | 36 | P11532 | |
| HVEVARLLLDSGAQV | 446 | O75179 | |
| VELLLARGANKEHRN | 1166 | O75179 | |
| LSHNDIRVLRAGAFD | 106 | O15335 | |
| LLFGGDIEVQHRERL | 1296 | Q7Z478 | |
| QVLQEHLGRESDLFL | 196 | P18075 | |
| LQQHRDFIALREELG | 846 | Q6W2J9 | |
| LLAEYEAGQARLRVH | 311 | Q8TF44 | |
| EAGQARLRVHLLAAE | 316 | Q8TF44 | |
| DGINAAFLDRIRHQV | 181 | Q7L9B9 | |
| LDQLIEALNSRGHRE | 901 | Q9NRL2 | |
| ALDHTADRLQAILGV | 141 | P01019 | |
| ALQRLLAEHDAVRNA | 101 | Q99929 | |
| LLQGQRHGVFLVRDS | 26 | P46108 | |
| QELLARLGQQLRHDD | 316 | Q149M9 | |
| LDLFRLLDQNRDGHL | 191 | Q9NXG6 | |
| RDGHLQLREVLAQTR | 201 | Q9NXG6 | |
| ENIERRNHYLDLAGI | 251 | Q969G9 | |
| GQDLREQLAEGHRLA | 141 | Q96M43 | |
| HLEELDLGDNRQLRT | 101 | Q86UN2 | |
| QALEELDLGDNRHLR | 106 | Q86UN3 | |
| GRATARNELLHFERA | 3341 | P98160 | |
| AEGQRELEAQLSHLR | 271 | Q7Z6P3 | |
| RLQAQEHGAERLRIE | 431 | Q9H5N1 | |
| HGADAARRFILTILN | 341 | Q8TE59 | |
| GDRLARLFLEEHIRN | 71 | Q8TBF8 | |
| DILDRIATEAGQLAH | 91 | P0C1H6 | |
| LLRLVDENLLFHGEA | 306 | P35557 | |
| VLLDVNGHIRLADFG | 201 | Q6DT37 | |
| QALGLRDVHLALSED | 171 | O00255 | |
| LLELQAHVRGEAAAR | 51 | Q9HD47 | |
| VLHRILGDFLVAVNE | 476 | Q9UJX3 | |
| AARSGHDQVVELLLE | 306 | Q01484 | |
| HRDLAARNVLLAQGK | 816 | P16234 | |
| HREGTLGQQARDALL | 221 | Q8N612 | |
| LRFRHENIIGINDII | 76 | P28482 | |
| QIVRHDDLLLGDYRL | 161 | C9J6K1 | |
| DVALEHLENCRGLER | 356 | Q9UKC9 | |
| LGKDNRLLEHNRSVL | 526 | Q96PR1 | |
| RTLEGELHDLRGQVA | 156 | P02545 | |
| GAAHEELQQSRIRID | 286 | P02545 | |
| SLLIAFQRLHEDERG | 281 | Q5T9C9 | |
| GNFRDAVIAHEQRLL | 216 | P81274 | |
| RASAHLDQVFGLNLR | 131 | Q8TD90 | |
| RVRAALSHDGILNLE | 131 | Q16082 | |
| REELAQFHRDGALTQ | 576 | P16435 | |
| RDAHGAIQDLLSERE | 241 | Q9H2G9 | |
| REFLALRDRLHAAEQ | 41 | Q9UQ53 | |
| LQREGGATLARLQHD | 781 | Q5JYT7 | |
| VRLGRLEAAIHQVSD | 841 | Q5JYT7 | |
| DLARLLEQGTLAEEH | 111 | P31152 | |
| TLGDREAILQRLDHL | 56 | Q9HCQ5 | |
| FLVLHVRRNNLVGDA | 701 | Q15034 | |
| AQLRLRELGHEKDSL | 56 | O75145 | |
| AGAFADLRALRALHL | 106 | Q9P244 | |
| RALHLDSNRLAEVRG | 116 | Q9P244 | |
| LLDAAAGIHVRFRLG | 61 | Q8NCR3 | |
| LDEVELHFGAQVRRL | 71 | Q8N4P3 | |
| RQGELDVLRSLHAAG | 11 | B1AK53 | |
| LLVFEQLIVDGRREH | 811 | A9Z1Z3 | |
| GINAIFERLRNILHE | 311 | Q9HCG8 | |
| RLLTIGDANGEIQRH | 36 | Q86X55 | |
| LAEFARLQDQLDHRG | 276 | Q96D31 | |
| AHNLIAIARLRGSDL | 471 | Q7Z6M2 | |
| VRERILGADNIDVSH | 331 | Q9UK73 | |
| FRALGLRHLVVVDNR | 761 | P51798 | |
| DELNQLERVFLRLGH | 11 | Q5VYK3 | |
| EQGARLGRNHVEELL | 1026 | O95382 | |
| GLRHFLDRVLEGRAQ | 301 | Q969U6 | |
| VQELRQRHGQALGEL | 1211 | Q7Z406 | |
| RLAAELHEQAQALER | 1711 | A7E2Y1 | |
| LHEQAQALERRASLL | 1716 | A7E2Y1 | |
| REIRLLGRNLHLFQD | 931 | O43157 | |
| HLNEDTGRFVLLAAL | 31 | Q9HB15 | |
| ALRDEVGHLALALEA | 121 | Q9H6K4 | |
| AFGEERRLDVLQAIH | 186 | Q7Z412 | |
| AEGFVDALHRVRQIA | 16 | Q96I24 | |
| LINDALHRSGQIERG | 1031 | Q9Y4C0 | |
| RRHNADDIVATGLAV | 821 | Q9P265 | |
| RVAHEEERVGLNAQA | 141 | P48681 | |
| LDRELRFLSDANGLH | 141 | Q7LBC6 | |
| FQDLHSLRRLEVGDN | 146 | P0C6S8 | |
| ARHTQAELQRALAEG | 1456 | P55268 | |
| EEQRRLGANSGLHII | 311 | P46459 | |
| QLEGEARDLISRLHD | 106 | H0YM25 | |
| HDATRDLVLLGEQFR | 346 | Q02153 | |
| ALREGLIRQHEQEAA | 86 | Q96N16 | |
| GHLNEDNARFLLLAA | 11 | Q9HB14 | |
| GAFADLRALRALHLD | 101 | Q9BTN0 | |
| AINQRLLAEELHRAA | 76 | O15553 | |
| ARGERLEDQVHALVR | 141 | A6NGR9 | |
| QDAAGHRQLLLRELQ | 366 | O94927 | |
| HDVAEDLGLLQFVRL | 51 | P18054 | |
| VLLDVNGHIRLADFG | 206 | Q9Y5S2 | |
| HNRAGVRQLFALDLV | 286 | Q9UN70 | |
| NQRHFRVDLDSGALL | 71 | Q9Y5F7 | |
| EDGDAHVLLQLRQRF | 301 | Q8IZL8 | |
| LLVGNDDVHIIARSD | 2606 | Q7Z6Z7 | |
| RRHLQGREDNLTLDI | 1336 | P63135 | |
| LHRRLAGQFLEELRN | 231 | Q16653 | |
| QATELHVLDVAGNRL | 356 | Q9BTT6 | |
| HLRAGASEQELLRII | 341 | Q9NZB8 | |
| RLLQHFQDGGERALA | 106 | Q5BKU9 | |
| DDLERVRQLGHALLV | 166 | P26010 | |
| AVFQLGDLHRALELT | 216 | O15460 | |
| LRQLQEFTDLGHRLD | 96 | O75864 | |
| AEVVFFENGLRHLLL | 4386 | Q5VST9 | |
| SILRHAADLLREQAN | 186 | Q96HP4 | |
| RLLQFLSIVARHADD | 521 | O43182 | |
| VDNEIELLRAGAFLH | 451 | Q14392 | |
| QQALEDLIARLGRSH | 211 | Q96JP2 | |
| GLDQLRELSLAHNRL | 451 | Q6PEZ8 | |
| LELHRGQDAAARLLR | 376 | Q86VR8 | |
| GAARGQLRLEQEHLL | 161 | P12036 | |
| LREIRAQLEGHAVQS | 271 | P12036 | |
| RVENNDLVIARILHG | 146 | Q9NZW5 | |
| FARLLRLQESSQGEH | 281 | Q9UP65 | |
| TFGDLLRLERLFLHN | 141 | A1KZ92 | |
| RLGQHIEDALLDVAS | 746 | Q8TCG5 | |
| QGAGVESLDFRLHLR | 291 | Q9Y4D1 | |
| EVFAFHLDRILGLNR | 276 | Q6UWH4 | |
| SIIRDLGALAQVHAE | 186 | O14531 | |
| DLHAFENLEIIRGRT | 416 | P00533 | |
| LEINARDREGDTALH | 271 | Q9GZV1 | |
| DFQGLHNELLLRIGE | 1071 | Q13535 | |
| EAVFLENLRHAAGVL | 126 | Q5T013 | |
| ENLRHAAGVLAQEDL | 131 | Q5T013 | |
| RRELVNAGVVHVALL | 331 | Q8TCB0 | |
| HDILLRDVASGQRVV | 66 | Q5T6J7 | |
| DIDRLHNLRAVFTDL | 271 | Q14185 | |
| RRHLQGREDNLTLDI | 576 | P61570 | |
| RRHLQGREDNLTLDI | 576 | Q69384 | |
| AGGDARQELRELHRQ | 1141 | H7BZ55 | |
| EQAVLLVRRDRDGQH | 441 | Q99501 | |
| EQLDHGRAELDALLR | 131 | Q9BVV2 | |
| AAQLQERLAVLERHL | 601 | Q14393 | |
| DDLRQQRDVLDGHLR | 1631 | P15924 | |
| AFAEQLGRRALALHG | 446 | Q86WU2 | |
| DLLALIVAQHRDRSN | 796 | Q86WJ1 | |
| DLHRASENLRQEGVR | 1961 | P12111 | |
| GEREELNLAVLHAFV | 116 | Q99418 | |
| RAHEALRTQLEGAQE | 286 | Q8N4Y2 | |
| HLAQLGRADALRVLS | 331 | Q9H665 | |
| HQRGRALEDLRAQLG | 51 | Q02410 | |
| GYVHRDLAARNILIN | 741 | P29320 | |
| LRLAESQARLDHDVA | 111 | Q6QNY0 | |
| DIIRNIARHLAQVGD | 81 | P55957 | |
| SGVEHGNLRELALAR | 376 | Q9H9T3 | |
| AAAAGHRLLAEQEVL | 851 | O00754 | |
| GHRGEAQADLRRVLL | 901 | Q9Y2E5 | |
| LVRGGHDIILAAFDN | 281 | O95466 | |
| LNVADRLADEHVLIG | 396 | Q9Y4J8 | |
| GRALEERAQQHREAL | 496 | Q15051 | |
| AHFRRDEFLGRINEI | 551 | Q9H078 | |
| ASVEERQRHLAGLAV | 331 | Q9Y6C2 | |
| LHQSLDGRELALRQE | 351 | Q9NT22 | |
| AGHRQVLNLRGELEQ | 646 | Q9NT22 | |
| AARLEAQARVHQLLL | 326 | O75052 | |
| RGLDISNVRHVINFD | 501 | O15523 | |
| RDQRQGERLEHAAAL | 296 | Q4V328 | |
| GERLEHAAALRALQD | 301 | Q4V328 | |
| VAHILGIRDLAAVNL | 2131 | P49327 | |
| ILAEAQAHFGRRLGL | 296 | Q8NFF5 | |
| TVHLEIGLLLRNFDR | 156 | Q9BPU9 | |
| EAQVELLLHRQRDLG | 1076 | Q9C0D2 | |
| ANLRRQFKELLEDHG | 681 | Q14147 | |
| IADRLEAGLEQVHLA | 681 | O75923 | |
| IAVALGENHSRALLD | 311 | O94829 | |
| FEQASIVEALLRHLG | 121 | Q5EB52 | |
| DGVLLAAERRNIHKL | 41 | P25789 | |
| SNIDQVARHLRGLLE | 156 | Q8N4L8 | |
| FAEGVLRRTERLQAH | 246 | Q6VVB1 | |
| DEVAQAAEALRHRGI | 1116 | A6NMZ7 | |
| TREAFNLLLRVNHIG | 131 | Q6UX07 | |
| ERIDQLFAVGGLRHL | 66 | Q8TE73 | |
| ALDVSHNLLRALDVG | 71 | P98161 | |
| NEGRRHAAVLVLREL | 161 | P42345 | |
| NRDDRIHGALLILNE | 256 | P42345 | |
| EGLSRLLRQHAEDLN | 81 | P07332 | |
| EARRLRSALLFQHED | 141 | Q96J94 | |
| LDSLDQIIQHLAGRA | 366 | Q9NZ71 | |
| RFSRHDLIGQVVLDN | 391 | Q9BQG1 | |
| AERFENLREIGNLLH | 126 | P49591 | |
| GLSRHQLGREAFLQE | 401 | P26640 | |
| IDDHFRIGVAILQRS | 421 | Q68CQ4 | |
| HSQVAGRLIIRAEEL | 76 | Q9BZX4 | |
| RINHNERLEFLGDAV | 961 | Q9NRR4 | |
| HRDLDGFLAQASIVL | 111 | Q8NBS3 | |
| VHRDLRAANILVGEN | 386 | P12931 | |
| DILQRLRENAAHLGD | 221 | Q9HCM9 | |
| LRENAAHLGDKRRDL | 226 | Q9HCM9 | |
| DVELLQAFGDILHRS | 241 | P0CI25 | |
| NHELRIAGGAVRDLL | 56 | Q96Q11 | |
| FLLAQLRDGRHVVLG | 141 | Q9NP31 | |
| GQLAELRQRLDHAEA | 631 | P12757 | |
| GQLNAEHAEADVRRV | 91 | Q15750 | |
| GQDLREQLAEGHRLA | 141 | Q86XG9 | |
| GQDLREQLAEGHRLA | 141 | Q5VWK0 | |
| ARALRLGLEALAANH | 141 | Q9Y2Z4 | |
| IHDAVLGSQLREALA | 706 | P58743 | |
| VEGREFQLHRLVLSA | 51 | Q9NVX7 | |
| LERARHQLQLELGDA | 1426 | Q9Y2K3 | |
| QLHLAGLRRFDAAQV | 56 | Q9H469 | |
| LLLSVNARGLLEFEH | 166 | Q14697 | |
| QLNLSHGALRFIRLE | 326 | A3QJZ6 | |
| VREHGIRLLEAQIAT | 2331 | P58107 | |
| ARRDELLAQHAAGAL | 2671 | P58107 | |
| EARRDELLAQHAAGA | 3201 | P58107 | |
| ARRDELLAQHAAGAL | 3736 | P58107 | |
| RRDELLAQHAAGALG | 4271 | P58107 | |
| VREHGIRLLEAQIAT | 4466 | P58107 | |
| ERHLIDGDVVLFNRQ | 451 | O14802 | |
| HRVDILQGAEIVFLA | 131 | Q8IW03 | |
| RAREAVLDAHFLVLA | 126 | Q9NXX6 | |
| ILEVNGRSFLNILHD | 326 | Q9P202 | |
| GRSFLNILHDEAVRL | 331 | Q9P202 | |
| EAAEIHLRLGQIQRY | 821 | Q8IZU2 | |
| FLAERGGRALHAELV | 21 | Q53LP3 | |
| LRDRLFHAQGSAVLG | 776 | Q9NQW1 | |
| REAQRQQLHLGALGE | 71 | Q5SSQ6 | |
| LERIFQLSEAHGALA | 1901 | Q6ZRS2 | |
| AGDLANELVRHFLIE | 1226 | Q68CZ2 | |
| QDRVAELHRLLSLQG | 1256 | Q9Y2I6 | |
| QAAAIIDHERIALGN | 1231 | Q5VT25 | |
| FLLQARRVSDHQIAG | 81 | A0A1B0GV85 | |
| KRAILGQEEALRLHA | 411 | Q8TCX5 | |
| SGLEAELEHLRQALE | 536 | P12755 | |
| SAGLERLAQEEAQHR | 466 | Q5JTZ9 | |
| LHLDNLGEDVREALS | 1231 | Q9NRC6 | |
| RRHVEALQQVGRELL | 1366 | Q9NRC6 | |
| LEAQLRSHQGLEREL | 1871 | Q9NRC6 | |
| LRRAEARGHGLQEQL | 3091 | Q9NRC6 | |
| RLEGDHQLLQESLVF | 701 | Q08043 | |
| FSEGNILELLHRLDV | 276 | Q9BPX3 | |
| GLRFAHLLDQVSRVD | 351 | Q96SZ6 | |
| LLAHARELGVLVFEN | 421 | Q92759 | |
| GSENREAAGRLHRLL | 181 | Q9C0B9 | |
| GIAHLAQDDATIVRL | 466 | Q99570 | |
| IHNAEERRALAGARD | 176 | Q07352 | |
| LGEEVRLHLNAELGR | 191 | Q8NCJ5 | |
| RLHLNAELGREDDSV | 196 | Q8NCJ5 | |
| FHGLDEATLLRALQA | 141 | Q9BRG1 | |
| QSAHLAELIAELEGR | 221 | Q96F44 | |
| GHIQTLLRAFEARDR | 171 | Q9Y3A6 | |
| RRLFGHAQLIQSDDD | 131 | Q9NQ34 | |
| EALLAQHAALRGEVE | 1101 | O15020 | |
| NEFVLLHLLGVRDAG | 166 | Q9H310 | |
| IHRDLAARNVLVGEN | 976 | P35590 | |
| EQHLARLSEIFAARG | 151 | Q9BSA4 | |
| HSQVAGRLIIRAEEL | 76 | Q9HAT0 | |
| QALLRKHEGLERDLA | 291 | Q13813 | |
| EAELHANADRIRGVI | 1596 | Q13813 | |
| EADRRRAQLHVQGLL | 486 | Q9H2V7 | |
| DVELLQAFGDILHRS | 241 | P0CI26 | |
| QLVLAEAHDSLRGLQ | 586 | O94964 | |
| ALDLAAINIQRGRDH | 1151 | Q92626 | |
| RAGLHELIQDAAARR | 221 | Q96BV0 | |
| IRNLDDELHAIIAGF | 321 | Q86UB9 | |
| DVRARLQRAGQEHLL | 6 | Q3KQV9 | |
| LLIEHGADIRAQDSL | 221 | Q9H1D0 | |
| AFLLDGLHEDLNRIR | 386 | Q9Y4E8 | |
| VANEDGRRVAAILNH | 2586 | Q6N022 | |
| LQRAFRTAEQHLGLA | 241 | Q9H254 | |
| AHGREEASDRRLQQL | 266 | Q96NL6 | |
| LRGLDAHLEQIFQEA | 686 | P11277 | |
| IHRDLAARNILVGEN | 961 | Q02763 | |
| EAEALGREHAAQRLF | 81 | P36402 | |
| QLDEGLFSRLRNLHD | 206 | Q6EMK4 | |
| VHRDLAARNILVAEG | 871 | P07949 | |
| LQAILEAERRDRGHD | 606 | Q13464 | |
| TLHRRDGIFENNIIV | 416 | O15060 | |
| VLLVHGNRREQALEE | 361 | F5GYI3 | |
| RNHESALQLGLGERE | 91 | Q8NEG5 | |
| LGLQFHSRILDIDNV | 361 | O43615 | |
| DVELLQAFGDILHRS | 241 | C9J1S8 | |
| DGRVDVHELRQGLAR | 26 | Q9BV35 | |
| DGVIRELAARALHNL | 576 | Q9BTW9 | |
| LRELAGVEQALGLHD | 231 | Q5W5X9 | |
| LERREVEQQGFLHLG | 971 | Q6UXY8 | |
| DVELLQAFGDILHRS | 241 | A6NDI0 | |
| DIRNLKEELQVFRGH | 316 | Q9C0J8 | |
| EQRERLHGALALIEL | 326 | Q7RTV3 | |
| LGLEEHLNALDRAAG | 386 | Q3LXA3 | |
| FLRFLLDGLHNEVNR | 361 | O75604 | |
| AGTLAVLQRLIHDRE | 521 | A3KMH1 | |
| AGLEVHRLVLGEFRN | 251 | O00206 | |
| HRLVLGEFRNEGNLE | 256 | O00206 | |
| LHFDAERLGQGRARL | 126 | Q9Y334 | |
| GRALRDLDHVLQEAL | 441 | A8MYJ7 | |
| LLSQRRFVLLHNGEA | 556 | Q6ZVT0 | |
| AERLALHDQQLRAAL | 41 | Q2NL98 | |
| LHDQQLRAALDELGR | 46 | Q2NL98 | |
| VQDLESLGRHQREAL | 521 | Q8IYH5 | |
| LDNLVAIFDVNRLGH | 146 | P51854 | |
| EDLKQRLGHRLQLTD | 2081 | O75962 | |
| LLIEHGADIRAQDSL | 181 | Q9NQA5 | |
| HRDLAARNVLLDNDR | 1021 | P29597 | |
| NYIHRDLRAANILVG | 391 | P07947 | |
| HNALRDVVLIGEQAR | 406 | Q02108 | |
| QHLRKELERVAGALQ | 301 | A6NN73 | |
| ALQRLDLRENGLHSV | 96 | Q2I0M4 | |
| LLERLNLGDNRVTHI | 336 | O94898 | |
| EHFFVRLLNLRVGDA | 476 | Q9UPR5 | |
| AVHRNIRDDEGFIIR | 566 | Q9UM54 | |
| ADLLEEHLGEIRNLR | 1841 | Q5VU43 | |
| HLVAEVRALRGQLEQ | 2046 | Q5VU43 | |
| AAHRDGRIQVNDLLV | 536 | Q96SB3 | |
| VTADARALLAGQRHL | 466 | Q00653 |